WO2008106254A2 - Two piece cancellous construct for cartilage repair - Google Patents
Two piece cancellous construct for cartilage repair Download PDFInfo
- Publication number
- WO2008106254A2 WO2008106254A2 PCT/US2008/051796 US2008051796W WO2008106254A2 WO 2008106254 A2 WO2008106254 A2 WO 2008106254A2 US 2008051796 W US2008051796 W US 2008051796W WO 2008106254 A2 WO2008106254 A2 WO 2008106254A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bore
- cartilage
- base member
- repair assembly
- cap member
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3859—Femoral components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
- A61F2002/2839—Bone plugs or bone graft dowels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30057—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis made from both cortical and cancellous adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30059—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in bone mineralization, e.g. made from both mineralized and demineralized adjacent parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/30225—Flat cylinders, i.e. discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/30225—Flat cylinders, i.e. discs
- A61F2002/30227—Flat cylinders, i.e. discs arched, domed or vaulted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/30233—Stepped cylinders, i.e. having discrete diameter changes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/30235—Three-dimensional shapes cylindrical tubular, e.g. sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30317—The prosthesis having different structural features at different locations within the same prosthesis
- A61F2002/30327—The prosthesis having different structural features at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30331—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
- A61F2002/30354—Cylindrically-shaped protrusion and recess, e.g. cylinder of circular basis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30448—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30459—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30461—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
- A61F2002/30492—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism using a locking pin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30604—Special structural features of bone or joint prostheses not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A61F2002/30759—Mosaicplasty, i.e. using a plurality of individual cartilage plugs for filling a substantial cartilage defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A61F2002/30762—Means for culturing cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
- A61F2002/30764—Cartilage harvest sites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
- A61F2002/30784—Plurality of holes
- A61F2002/30785—Plurality of holes parallel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
- A61F2002/30784—Plurality of holes
- A61F2002/30789—Plurality of holes perpendicular with respect to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30795—Blind bores, e.g. of circular cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/30932—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for retarding or preventing ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2002/4635—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor using minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4644—Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material
- A61F2002/4646—Devices for cleaning bone graft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4644—Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material
- A61F2002/4649—Bone graft or bone dowel harvest sites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0066—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Definitions
- the present invention is generally directed toward an allograft cartilage repair implant and is more specifically directed toward a two piece allograft cancellous bone implant having a demineralized cancellous bone cap member and a mineralized or partially demineralized cancellous bone base member, both pieces being held together with an allograft bone pin.
- the construct is shaped for an interference fit implantation in a shoulder, knee, hip, or ankle joint.
- the base member is provided with an axially positioned blind bore and a plurality of smaller diameter through going bores which allow transport of cellular materials throughout the implant site to stimulate cartilage growth
- the articular cartilage tissue forms a lining which faces the joint cavity on one side and is linked to the subchondral bone plate by a narrow layer of calcified cartilage tissue on the other.
- Articular cartilage hyaline cartilage
- Articular cartilage consists primarily of extracellular matrix with a sparse population of chondrocytes distributed throughout the tissue.
- Articular cartilage is composed of chondrocytes, type II collagen fibril meshwork, proteoglycans and water. Active chondrocytes are unique in that they have a relatively low turnover rate and are sparsely distributed within the surrounding matrix.
- the collagens give the tissue its form and tensile strength and the interaction of proteoglycans with water give the tissue its stiffness to compression, resilience and durability.
- the hyaline cartilage provides a low friction bearing surface over the bony parts of the joint. If the lining becomes worn or damaged resulting in lesions, joint movement may be painful or severely restricted. Whereas damaged bone typically can regenerate successfully, hyaline cartilage regeneration is quite limited because of it's limited regenerative and reparative abilities.
- Articular cartilage lesions generally do not heal, or heal only partially under certain biological conditions due to the lack of nerves, blood vessels and a lymphatic system.
- the limited reparative capabilities of hyaline cartilage usually results in the generation of repair tissue that lacks the structure and biomechanical properties of normal cartilage.
- the healing of the defect results in a fibrocartilaginous repair tissue that lacks the structure and biomedical properties of hyaline cartilage and degrades over the course of time.
- Articular cartilage lesions are frequently associated with disability and with symptoms such as joint pain, locking phenomena and reduced or disturbed function. These lesions are difficult to treat because of the distinctive structure and function of hyaline cartilage. Such lesions are believed to progress to severe forms of osteoarthritis.
- Osteoarthritis is the leading cause of disability and impairment in middle-aged and older individuals, entailing significant economic, social and psychological costs. Each year, osteoarthritis accounts for as many as 39 million physician visits and more than 500,000 hospitalizations. By the year 2020, arthritis is expected to affect almost 60 million persons in the United States and to limit the activity of 11.6 million persons. There are many current therapeutic methods being used. None of these therapies has resulted in the successful regeneration of hyaline- like tissue that withstands normal joint loading and activity over prolonged periods. Currently, the techniques most widely utilized clinically for cartilage defects and degeneration are not articular cartilage substitution procedures, but rather lavage, arthroscopic debridement, and repair stimulation.
- the direct transplantation of cells or tissue into a defect and the replacement of the defect with biologic or synthetic substitutions presently accounts for only a small percentage of surgical interventions.
- the optimum surgical goal is to replace the defects with cartilage-like substitutes so as to provide pain relief, reduce effusions and inflammation, restore function, reduce disability and postpone or alleviate the need for prosthetic replacement.
- Lavage and arthroscopic debridement involve irrigation of the joint with solutions of sodium chloride, Ringer or Ringer and lactate.
- the temporary pain relief is believed to result from removing degenerative cartilage debris, proteolytic enzymes and inflammatory mediators. These techniques provide temporary pain relief, but have little or no potential for further healing.
- Repair stimulation is conducted by means of drilling, abrasion arthroplasty or microfracture. Penetration into the subchondral bone induces bleeding and fibrin clot formation which promotes initial repair, however, the tissue formed is fibrous in nature and not durable. Pain relief is temporary as the tissue exhibits degeneration, loss of resilience, stiffness and wear characteristics over time.
- the periosteum and perichondrium have been shown to contain mesenchymal progenitor cells capable of differentiation and proliferation. They have been used as grafts in both animal and human models to repair articular defects. Few patients over 40 years of age obtain good clinical results, which most likely reflect the decreasing population of osteochondral progenitor cells with increasing age. There have also been problems with adhesion and stability of the grafts, which result in their displacement or loss from the repair site.
- CARTICELl ® is a commercial process to culture a patient's own cartilage cells for use in the repair of cartilage defects in the femoral condyle marketed by Genzyme Biosurgery in the United States and Europe.
- the procedure uses arthroscopy to take a biopsy from a healthy, less loaded area of articular cartilage. Enzymatic digestion of the harvested tissue releases the cells that are sent to a laboratory where they are grown for a period ranging from 2-5 weeks. Once cultivated, the cells are injected during a more open and extensive knee procedure into areas of defective cartilage where it is hoped that they will facilitate the repair of damaged tissue.
- An autologous periosteal flap with a cambium layer is used to seal the transplanted cells in place and act as a mechanical barrier. Fibrin glue is used to seal the edges of the flap. This technique preserves the subchondral bone plate and has reported a high success rate. Proponents of this procedure report that it produces satisfactory results, including the ability to return to demanding physical activities, in more than 90% of patients and those biopsy specimens of the tissue in the graft sites show hyaline-like cartilage repair. More work is needed to assess the function and durability of the new tissue and determine whether it improves joint function and delays or prevents joint degeneration.
- Osteochondral transplantation or mosaicplasty involves excising all injured or unstable tissue from the articular defect and creating cylindrical holes in the base of the defect and underlying bone. These holes are filled with autologous cylindrical plugs of healthy cartilage and bone in a mosaic fashion. The osteochondral plugs are harvested from a lower weight-bearing area of lesser importance in the same joint. This technique, shown in Prior Art Figure 2, can be performed as arthroscopic or open procedures. Reports of results of osteochondral plug autografts in a small numbers of patients indicate that they decrease pain and improve joint function, however, long-term results have not been reported.
- Factors that can compromise the results include donor site morbidity, effects of joint incongruity on the opposing surface of the donor site, damage to the chondrocytes at the articular margins of the donor and recipient sites during preparation and implantation, and collapse or settling of the graft over time.
- the limited availability of sites for harvest of osteochondral autografts restricts the use of this approach to treatment of relatively small articular defects and the healing of the chondral portion of the autograft to the adjacent articular cartilage remains a concern.
- Transplantation of large allografts of bone and overlying articular cartilage is another treatment option that involves a greater area than is suitable for autologous cylindrical plugs, as well as for a non-contained defect.
- osteochondral allografts are the potential to restore the anatomic contour of the joint, lack of morbidity related to graft harvesting, greater availability than autografts and the ability to prepare allografts in any size to reconstruct large defects.
- Clinical experience with fresh and frozen osteochondral allografts shows that these grafts can decrease joint pain, and that the osseous portion of an allograft can heal to the host bone and the chondral portion can function as an articular surface.
- Drawbacks associated with this methodology in the clinical situation include the scarcity of fresh donor material and problems connected with the handling and storage of frozen tissue. Fresh allografts cany the risk of immune response or disease transmission.
- Musculoskeletal Transplant Foundation has preserved fresh allografts in a media that maintains a cell viability of 50% for 35 days for use as implants. Frozen allografts lack cell viability and have shown a decreased amount of proteoglycan content which contribute to deterioration of the tissue.
- U.S. Patent Number 4,950,296 issued August 21, 1990 discloses a bone graft device comprising a cortical shell having a selected outer shape and a cavity formed therein for receiving a cancellous plug, which is fitted into the cavity in a manner to expose at least one surface
- U.S. Patent Number 6,039,762 issued March 21, 2000 discloses a cylindrical shell with an interior body of deactivated bone material
- U.S. Patent Number 6,398,811 issued June 4 ,2002 directed toward a bone spacer which has a cylindrical cortical bone plug with an internal through going bore designed to hold a reinforcing member.
- U.S. Patent Number 6,383,211 issued May 7, 2002 discloses an invertebral implant having a substantially cylindrical body with a through going bore dimensioned to receive bone growth materials.
- U.S. Patent Number 6,379,385 issued April 30, 2002 discloses an implant base body of spongious bone material into which a load carrying support element is embedded.
- the support element can take the shape of a diagonal cross or a plurality of cylindrical pins.
- U.S. Patent Number 6,294, 187 issued September 25, 2001 which is directed to a load bearing osteoimplant made of compressed bone particles in the form of a cylinder.
- the cylinder is provided with a plurality of through going bores to promote blood flow through the osteoimplant or to hold a demineralized bone and glycerol paste mixture.
- U.S. Patent Number 6,096,081 issued August 1, 2000 shows a bone dowel with a cortical end cap or caps at both ends, a brittle cancellous body and a through going bore.
- the graft is then morselized in a bone graft crusher, mixing the articular cartilage with the cancellous bone.
- the paste is then pushed into the defect and secured by the adhesive properties of the bleeding bone.
- the paste can also be mixed with a cartilage stimulating factor, a plurality of cells, or a biological glue. All patients are kept non-weight bearing for four weeks and used a continuous passive motion machine for six hours each night Histologic appearance of the biopsies has mainly shown a mixture of fibrocartilage with hyaline cartilage. Concerns associated with this method are harvest site morbidity and availability, similar to the mosaicplasty method.
- U.S. Patent Number 6,379,367 issued April 30, 2002 discloses a plug with a base membrane, a control plug, and a top membrane which overlies the surface of the cartilage covering the defective area of the joint.
- a cartilage repair allograft construct implant comprising a two piece allograft bone construct with a mineralized cylindrical cancellous bone base member and a demineralized and non- osteoinductive cancellous bone cap member mounted in a blind bore cut in the cancellous bone base member, the two members being held together by an allograft bone pin.
- the two piece construct is used for replacing articular cartilage defects and is placed in a bore which has been cut into the patient to remove the lesion defect area.
- the bone base member has an axially aligned blind bore, a transverse through going bore which intersects the blind bore and has a plurality of through going bores which run parallel to the axis of the cylindrical bone base member.
- the cap member has a stem which fits into the blind bore of the base member with the stem defining a transverse through going bore.
- the base surface of the cap member body overlies the upper surface of the cylindrical base member with the stem bore and the base member transverse bore being aligned to receive a cortical pin.
- Additives may be applied to the internal bores, blind bore or the cap member of the construct in order to increase or accelerate cartilaginous or bony tissue formation
- Each allograft construct can support the addition of a variety of chondrogenic stimulating factors including, but not limited to morselized allogeneic cartilage, growth factors (FGF-2, FGF-5, IGF-1, TGF- ⁇ , BMP-2, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin-like growth factor- 1, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog and parathyroid hormone- related peptide or bioactive glue.
- FGF-2, FGF-5, IGF-1, TGF- ⁇ , BMP-2, BMP-7, PDGF, VEGF human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin-like growth factor- 1, transforming growth factor-B
- Figure 1 shows the anatomy of a knee joint
- Figure 2 shows a schematic mosaicplasty as known in the prior art
- Figure 3 shows an exploded perspective view of the inventive two piece cancellous construct
- Figure 4 shows a top plan view of the two piece allograft cancellous construct assembly showing the blind bore and plurality of through going bores in phantom;
- Figure 5 shows a side elevation view of the two piece construct shown in Figure 4.
- Figure 6 is a side elevation view of the two piece construct of Figure 4 turned 90 ° with the blind and parallel bores shown in phantom;
- Figure 7 shows a perspective view of the base member of the cancellous construct with the cap member removed
- Figure 8 shows a perspective view of the cap member of the cancellous construct
- Figure 9 is a side elevation view of the cap member shown in Figure 8.
- Figure 10 is a side elevation view of the cap member of the construct of Figure 9 turned 90°.
- tissue is used in the general sense herein to mean any transplantable or implantable tissue, the survivability of which is improved by the methods described herein upon implantation, In particular, the overall durability and longevity of the implant are improved, and host-immune system mediated responses, are substantially eliminated.
- transplant and “implant” are used interchangeably to refer to tissue, material or cells (xenogeneic or allogeneic) which may be introduced into the body of a patient.
- autograft refers to tissue or cells which originate with or are derived from the recipient, whereas the terms “allogeneic” and “allograft” refer to cells and tissue which originate with or are derived from a donor of the same species as the recipient.
- allogeneic and “allograft” refer to cells and tissue which originate with or are derived from a donor of the same species as the recipient.
- xenogeneic and “xenograft” refer to cells or tissue which originates with or are derived from a species other than that of the recipient.
- the present invention is directed towards a cartilage repair construct constructed of two separate pieces of allograft cancellous bone.
- Both pieces of the two-piece allograft construct are to be derived from dense cancellous bone that may originate from proximal or distal femur, proximal or distal tibia, proximal humerus, talus, calceneus, patella, or iliium.
- Cancellous tissue is first processed into blocks and then milled into the desired shapes.
- the top piece or cap member is substantially demineralized in dilute acid until the bone contains less than 0.2% wt/wt residual calcium.
- the resultant tissue form is predominantly Type I collagen, which is sponge-like in nature with an elastic quality.
- the tissue is further cleaned and may also be treated so that the cancellous tissue is non-osteoinductive.
- This inactivation of inherent osteoinductivity may be accomplished via chemical or thermal treatment or by high energy irradiation.
- the cancellous cap member is treated with an oxidizing agent such as hydrogen peroxide in order to achieve a non-osteoinductive material.
- the bottom piece will be formed from mineralized cancellous bone or partially demineralized cancellous bone.
- the two piece allograft cancellous construct 20 has a base member 22 with a cap member 30 which is held fixed in place in the base member by a pin 40.
- the base member 22 is preferably constructed of mineralized cancellous bone and is shaped in the form of a cylinder for easy insertion into bores cut into the patient to cut away cartilage defect areas.
- the base member 22 may be surface or partially demineralized or contain a region of cortical bone so that it is cortical/cancellous.
- the body of the base member 22 defines a blind bore 23 which holds the stem 36 of the cap member 30.
- the bottom surface 24 of the blind bore as seen in Figures 5-7 has a plurality of longitudinal through going bores 25 extending through the base member 22 and ending on the distal end surface 26 of the base member which is preferably planar.
- the top surface 27 of the base member 22 is also preferably planar forming a seat for the cap member 30.
- a transverse bore 28 extends through the diameter of the cylindrical base above the bottom surface 24 of the blind bore 23 and intersects the blind bore 23.
- a second plurality of through going bores 29 are circumferentially positioned around the blind bore 23 parallel to the central axis of the base member 22 and extend from the top surface 27 to the bottom surface 26.
- the through going bores 25 and 29 have a smaller diameter than the blind bore 23 with a diameter ranging from 0.5 to 2.0 mm
- the cap member 30 has a cylindrical top section 32 which has a thickness of about 3mm with a top planar surface 33, an outer curved wall 34 and a bottom planar surface 35 which is seated adjacent the top surface 27 of the base member 22 when the components are mounted together.
- the top surface 33 while preferably planar may be milled to a degree of curvature that makes the implant construct match the physiological curvature in the knee.
- Larger constructs may have a cap member that has multiple stem sections and a base with an inverse "female" pattern which receives the stem sections.
- An integral cylindrical stem 36 extends away from the bottom planar surface 35 a length which is not longer than the depth of the blind bore 23 and has a diameter equal to or less than the diameter of the blind bore 23.
- the stem 36 defines a transverse through going bore 37 which is aligned with transverse bore 28 of the base member to receive a cylindrical pin 40 which is inserted radially through the construct to hold the cap member 30 in place within the base member 22.
- the cap member 30 is preferably formed of demineralized cancellous allograft bone with a calcium content less than of 0.2 % calcium or has a substantially demineralized region such as the entire top section with a calcium content less than 0.2% calcium.
- the cylindrical pin 40 is preferably constructed of cortical bone and has a length equal to or less than the diameter of the base member 22.
- the pin can also be constructed of a synthetic material.
- the cap member 30 can be secured to the base member 22 by a staple, suture, press fit or an adhesive compound such as fibrin based glue.
- the construct 20 is placed in a defect area bore which has been cut in the lesion area of the bone of a patient with the upper surface 26 of the cap member 30 being slightly proud, slightly below, or substantially flush with the surface of the original cartilage remaining at the area being treated.
- the construct 20 has a length which can be the same as the depth of the defect or more or less than the depth of the bore. If the construct 20 is the same as the depth of the bore 60, the base of the implant is supported by the bottom surface of the bore and the top surface 33 of cap 30 is substantially level with the articular cartilage.
- the base of the construct is not supported but support is provided by the wall of the defect area bore or respective cut out area as the plug is interference fit within the bore or cut out area with the cap being slightly proud, slightly below, or flush with the surrounding articular cartilage depending on the surgeon's preference.
- the graft surface is not damaged by weight or bearing loads which can cause micromotion interfering with the graft interface producing fibrous tissue interfaces and subchondral cysts.
- a plurality of through going bores 25 and 29 in the construct allow cell migration throughout the construct to promote cartilage growth in the cartilage area and bone growth in the adjacent bore region.
- the lesion or defect is removed by cutting a bore removing a lesion in the implant area.
- the open cancellous structure of the cap member 30 may be loaded with a cartilage paste or gel as noted below and/or one or more additives namely recombinant or native growth factors (FGF-2, FGF-5, FGF-7, IGF-1, TGF- ⁇ , BMP-2, BMP-4, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic cells, human allogenic or autologous bone marrow cells, human allogenic or autologous stem cells, demineralized bone matrix, insulin, insulin-like growth factor-1, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet- derived growth factor, Indian hedgehog parathyroid hormone-related peptide, viral vectors for growth factor or DNA delivery, nanoparticles, or platelet-rich plasma.
- the construct 20 is then placed in the bore or cut away area in an interface fit with the surrounding walls.
- suitable organic glue material can be used to keep the implant fixed in place in the implant area.
- suitable organic glue material can be found commercially, such as for example; TISSEEL ® or TISSUCOL .® (fibrin based adhesive; Immuno AG, Austria), Adhesive Protein ( Sigma Chemical, USA), Dow Corning Medical Adhesive B (Dow Corning, USA), fibrinogen thrombin, elastin, collagen, casein, albumin, keratin and the like.
- the base of the blind bore 33 of the construct can alternatively be provided with a matrix of minced cartilage putty or gel consisting of minced or milled allograft cartilage which has been lyophilized so that its water content ranges from 0.1 % to 8.0% ranging from 25% to 50% by weight, mixed with a carrier of sodium hyaluronate solution (HA) (molecular weight ranging from 7.0x 10 5 to 1.2 x 10 6 ) or any other bioabsorbable carrier such as hyaluronic acid and its derivatives, gelatin, collagen, chitosan, alginate, buffered PBS, Dextran, or polymers, the carrier ranging from ranging from 75% to 50% by weight.
- HA sodium hyaluronate solution
- the cartilage is milled to a size ranging up to 1 mm.
- the minced cartilage has been lyophilized so that its water content ranges from 0.1 % to 8.0%, ranging from 15% to 30% by weight and the carrier ranges from 85% to 70% by weight.
- the particle size of the cartilage when milled is less than or equal to 1 mm dry.
- the cartilage pieces can be processed to varying particle sizes and the HA or other carrier can have different viscosities depending on the desired consistency of the putty or gel.
- This cartilage matrix can be deposited into the matrix of the demineralized cap member. The putty or gel enhances the tissue integration between the plug and host tissue.
- demineralized bone matrix and/or growth factors such as (FGF-2, FGF-5, FGF-7, IGF-1, TGF- ⁇ , BMP-2, BMP-4, BMP-7, PDGF, VEGF) or soluble factors such as insulin, interleukin- 1 receptor antagonist, hepatocyte growth factor, Indian hedgehog and parathyroid hormone-related peptide, viral vectors for growth factor or DNA delivery, nanoparticles may be adsorbed or combined with the scaffold or the cartilage fragments.
- platelet- rich plasma may be added to the scaffold.
- cells which have been grown outside the patient can be inserted by syringe into the cancellous cap matrix before, during or after deposit of the construct 20 into the defect area.
- Such cells include allogenic or autologous, bone marrow cells, stem cells and chondrocyte cells.
- the cellular density of the cells preferably ranges from 1.0 x 10 8 to 5.0 x 10 8 or from about 100 million to about 500 million cells per cc of putty or gel mixture. This matrix can support the previously mentioned chondrogenic stimulating factors.
Abstract
The invention is directed toward a cartilage repair assembly comprising a shaped allograft two piece construct (20) with a demineralized cancellous cap (30) and a mineralized cylindrical base member (22) defining a blind bore (23) wrth a through going transverse bore (28) intersecting the blind bore (23). The demineralized cancellous cap (30) has a cylindrical top portion (32) and a smaller diameter cylindrical stem (36) extending away from the top portion (32) which fits into the blind bore (23) of the mineralized base member (22). The cap stem (36) defines a transverse through going bore (37) which is aligned with the through going bore (28) of the base member (22) to receive a cylindrical cortical pin (40) holding the cap (30) within the base member (22). The shaped structure (20) is dimensioned to fit in a drilled bore in a cartilage delect area so that the assembly engages the side wall of the drilled bore in an interference fit.
Description
TWO PIECE CANCELLOUS CONSTRUCT FOR CARTILAGE REPAIR
RELATED APPLICATIONS
There is no related application.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO SEQUENCE LISTING. A TABLE OR A COMPUTER PROGRAM LISTING COMPACT DISC APPENDIX
None.
BACKGROUND OF THE INVENTION
1. Field of Invention
The present invention is generally directed toward an allograft cartilage repair implant and is more specifically directed toward a two piece allograft cancellous bone implant having a demineralized cancellous bone cap member and a mineralized or partially demineralized cancellous bone base member, both pieces being held together with an allograft bone pin. The construct is shaped for an interference fit implantation in a shoulder, knee, hip, or ankle joint. The base member is provided with an axially positioned blind bore and a plurality of smaller diameter through going bores which allow transport of cellular materials throughout the implant site to stimulate cartilage growth
2. Description of the Prior Art
Articular cartilage injury and degeneration present medical problems to the general population which is constantly addressed by orthopedic surgeons. Every year in the United States,
over 500,000 arthroplasty or joint repair procedures are performed. These include approximately 125,000 total hip and 150,000 total knee arthroplasties and over 41 ,000 open arthroscopic procedures to repair cartilaginous defects of the knee.
In the knee joint, the articular cartilage tissue forms a lining which faces the joint cavity on one side and is linked to the subchondral bone plate by a narrow layer of calcified cartilage tissue on the other. Articular cartilage (hyaline cartilage) consists primarily of extracellular matrix with a sparse population of chondrocytes distributed throughout the tissue. Articular cartilage is composed of chondrocytes, type II collagen fibril meshwork, proteoglycans and water. Active chondrocytes are unique in that they have a relatively low turnover rate and are sparsely distributed within the surrounding matrix. The collagens give the tissue its form and tensile strength and the interaction of proteoglycans with water give the tissue its stiffness to compression, resilience and durability. The hyaline cartilage provides a low friction bearing surface over the bony parts of the joint. If the lining becomes worn or damaged resulting in lesions, joint movement may be painful or severely restricted. Whereas damaged bone typically can regenerate successfully, hyaline cartilage regeneration is quite limited because of it's limited regenerative and reparative abilities.
Articular cartilage lesions generally do not heal, or heal only partially under certain biological conditions due to the lack of nerves, blood vessels and a lymphatic system. The limited reparative capabilities of hyaline cartilage usually results in the generation of repair tissue that lacks the structure and biomechanical properties of normal cartilage. Generally, the healing of the defect results in a fibrocartilaginous repair tissue that lacks the structure and biomedical properties of hyaline cartilage and degrades over the course of time. Articular cartilage lesions are frequently associated with disability and with symptoms such as joint pain, locking phenomena and reduced or disturbed function. These lesions are difficult to treat because of the distinctive structure and function of hyaline cartilage. Such lesions are believed to progress to severe forms of osteoarthritis. Osteoarthritis is the leading cause of disability and impairment in middle-aged and older individuals, entailing significant economic, social and psychological costs. Each year, osteoarthritis accounts for as many as 39 million physician visits and more than 500,000 hospitalizations. By the year 2020, arthritis is expected to affect almost 60 million persons in the United States and to limit the activity of 11.6 million persons.
There are many current therapeutic methods being used. None of these therapies has resulted in the successful regeneration of hyaline- like tissue that withstands normal joint loading and activity over prolonged periods. Currently, the techniques most widely utilized clinically for cartilage defects and degeneration are not articular cartilage substitution procedures, but rather lavage, arthroscopic debridement, and repair stimulation. The direct transplantation of cells or tissue into a defect and the replacement of the defect with biologic or synthetic substitutions presently accounts for only a small percentage of surgical interventions. The optimum surgical goal is to replace the defects with cartilage-like substitutes so as to provide pain relief, reduce effusions and inflammation, restore function, reduce disability and postpone or alleviate the need for prosthetic replacement.
Lavage and arthroscopic debridement involve irrigation of the joint with solutions of sodium chloride, Ringer or Ringer and lactate. The temporary pain relief is believed to result from removing degenerative cartilage debris, proteolytic enzymes and inflammatory mediators. These techniques provide temporary pain relief, but have little or no potential for further healing.
Repair stimulation is conducted by means of drilling, abrasion arthroplasty or microfracture. Penetration into the subchondral bone induces bleeding and fibrin clot formation which promotes initial repair, however, the tissue formed is fibrous in nature and not durable. Pain relief is temporary as the tissue exhibits degeneration, loss of resilience, stiffness and wear characteristics over time.
The periosteum and perichondrium have been shown to contain mesenchymal progenitor cells capable of differentiation and proliferation. They have been used as grafts in both animal and human models to repair articular defects. Few patients over 40 years of age obtain good clinical results, which most likely reflect the decreasing population of osteochondral progenitor cells with increasing age. There have also been problems with adhesion and stability of the grafts, which result in their displacement or loss from the repair site.
Transplantation of cells grown in culture provides another method of introducing a new cell population into chondral and osteochondral defects. CARTICELl® is a commercial process to culture a patient's own cartilage cells for use in the repair of cartilage defects in the femoral condyle marketed by Genzyme Biosurgery in the United States and Europe. The procedure uses arthroscopy to take a biopsy from a healthy, less loaded area of articular cartilage. Enzymatic digestion of the
harvested tissue releases the cells that are sent to a laboratory where they are grown for a period ranging from 2-5 weeks. Once cultivated, the cells are injected during a more open and extensive knee procedure into areas of defective cartilage where it is hoped that they will facilitate the repair of damaged tissue. An autologous periosteal flap with a cambium layer is used to seal the transplanted cells in place and act as a mechanical barrier. Fibrin glue is used to seal the edges of the flap. This technique preserves the subchondral bone plate and has reported a high success rate. Proponents of this procedure report that it produces satisfactory results, including the ability to return to demanding physical activities, in more than 90% of patients and those biopsy specimens of the tissue in the graft sites show hyaline-like cartilage repair. More work is needed to assess the function and durability of the new tissue and determine whether it improves joint function and delays or prevents joint degeneration. As with the perichondrial graft, patient/donor age may compromise the success of this procedure as chondrocyte population decreases with increasing age. Disadvantages to this procedure include the need for two separate surgical procedures, potential damage to surrounding cartilage when the periosteal patch is sutured in place, the requirement of demanding microsurgical techniques, and the expensive cost of the procedure which is currently not covered by insurance.
Osteochondral transplantation or mosaicplasty involves excising all injured or unstable tissue from the articular defect and creating cylindrical holes in the base of the defect and underlying bone. These holes are filled with autologous cylindrical plugs of healthy cartilage and bone in a mosaic fashion. The osteochondral plugs are harvested from a lower weight-bearing area of lesser importance in the same joint. This technique, shown in Prior Art Figure 2, can be performed as arthroscopic or open procedures. Reports of results of osteochondral plug autografts in a small numbers of patients indicate that they decrease pain and improve joint function, however, long-term results have not been reported. Factors that can compromise the results include donor site morbidity, effects of joint incongruity on the opposing surface of the donor site, damage to the chondrocytes at the articular margins of the donor and recipient sites during preparation and implantation, and collapse or settling of the graft over time. The limited availability of sites for harvest of osteochondral autografts restricts the use of this approach to treatment of relatively small articular defects and the healing of the chondral portion of the autograft to the adjacent articular cartilage remains a concern.
Transplantation of large allografts of bone and overlying articular cartilage is another treatment option that involves a greater area than is suitable for autologous cylindrical plugs, as well as for a non-contained defect. The advantages of osteochondral allografts are the potential to restore the anatomic contour of the joint, lack of morbidity related to graft harvesting, greater availability than autografts and the ability to prepare allografts in any size to reconstruct large defects. Clinical experience with fresh and frozen osteochondral allografts shows that these grafts can decrease joint pain, and that the osseous portion of an allograft can heal to the host bone and the chondral portion can function as an articular surface. Drawbacks associated with this methodology in the clinical situation include the scarcity of fresh donor material and problems connected with the handling and storage of frozen tissue. Fresh allografts cany the risk of immune response or disease transmission. Musculoskeletal Transplant Foundation (MTF) has preserved fresh allografts in a media that maintains a cell viability of 50% for 35 days for use as implants. Frozen allografts lack cell viability and have shown a decreased amount of proteoglycan content which contribute to deterioration of the tissue.
A number of United States Patents have been specifically directed towards bone plugs which are implanted into a bone defect. Examples of such bone plugs are U.S. Patent Number 4,950,296 issued August 21, 1990 which discloses a bone graft device comprising a cortical shell having a selected outer shape and a cavity formed therein for receiving a cancellous plug, which is fitted into the cavity in a manner to expose at least one surface; U.S. Patent Number 6,039,762 issued March 21, 2000 discloses a cylindrical shell with an interior body of deactivated bone material and U.S. Patent Number 6,398,811 issued June 4 ,2002 directed toward a bone spacer which has a cylindrical cortical bone plug with an internal through going bore designed to hold a reinforcing member. U.S. Patent Number 6,383,211 issued May 7, 2002 discloses an invertebral implant having a substantially cylindrical body with a through going bore dimensioned to receive bone growth materials.
U.S. Patent Number 6,379,385 issued April 30, 2002 discloses an implant base body of spongious bone material into which a load carrying support element is embedded. The support element can take the shape of a diagonal cross or a plurality of cylindrical pins. See also, U.S. Patent Number 6,294, 187 issued September 25, 2001 which is directed to a load bearing osteoimplant made of compressed bone particles in the form of a cylinder. The cylinder is provided with a plurality of
through going bores to promote blood flow through the osteoimplant or to hold a demineralized bone and glycerol paste mixture. U.S. Patent Number 6,096,081 issued August 1, 2000 shows a bone dowel with a cortical end cap or caps at both ends, a brittle cancellous body and a through going bore.
While these implants have been used for bone tissue regeneration, the same will not work to repair cartilage areas due to the osteoinductive nature of the bone which causes bone growth.
The use of implants for cartilage defects is much more limited. Aside from the fresh allograft implants and autologous implants, U.S. Patent Number 6,110,209 issued November 5, 1998 shows the use an autologous articular cartilage cancellous bone paste to fill arthritic defects. The surgical technique is arthroscopic and includes debriding (shaving away loose or fragmented articular cartilage), followed by morselizing the base of the arthritic defect with an awl until bleeding occurs. An osteochondral graft is then harvested from the inner rim of the intercondylar notch using a trephine. The graft is then morselized in a bone graft crusher, mixing the articular cartilage with the cancellous bone. The paste is then pushed into the defect and secured by the adhesive properties of the bleeding bone. The paste can also be mixed with a cartilage stimulating factor, a plurality of cells, or a biological glue. All patients are kept non-weight bearing for four weeks and used a continuous passive motion machine for six hours each night Histologic appearance of the biopsies has mainly shown a mixture of fibrocartilage with hyaline cartilage. Concerns associated with this method are harvest site morbidity and availability, similar to the mosaicplasty method.
U.S. Patent Number 6,379,367 issued April 30, 2002 discloses a plug with a base membrane, a control plug, and a top membrane which overlies the surface of the cartilage covering the defective area of the joint.
SUMMARY OF THE INVENTION
A cartilage repair allograft construct implant comprising a two piece allograft bone construct with a mineralized cylindrical cancellous bone base member and a demineralized and non- osteoinductive cancellous bone cap member mounted in a blind bore cut in the cancellous bone base member, the two members being held together by an allograft bone pin. The two piece construct is used for replacing articular cartilage defects and is placed in a bore which has been cut into the
patient to remove the lesion defect area. The bone base member has an axially aligned blind bore, a transverse through going bore which intersects the blind bore and has a plurality of through going bores which run parallel to the axis of the cylindrical bone base member. The cap member has a stem which fits into the blind bore of the base member with the stem defining a transverse through going bore. The base surface of the cap member body overlies the upper surface of the cylindrical base member with the stem bore and the base member transverse bore being aligned to receive a cortical pin. Additives may be applied to the internal bores, blind bore or the cap member of the construct in order to increase or accelerate cartilaginous or bony tissue formation
Each allograft construct can support the addition of a variety of chondrogenic stimulating factors including, but not limited to morselized allogeneic cartilage, growth factors (FGF-2, FGF-5, IGF-1, TGF-β, BMP-2, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin-like growth factor- 1, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog and parathyroid hormone- related peptide or bioactive glue.
It is an object of the invention to provide an allograft implant for joints which provides pain relief, restores normal function and will postpone or alleviate the need for prosthetic replacement. It is also an object of the invention to provide a cartilage repair implant which is easily placed in a defect area by the surgeon using an arthroscopic, minimally invasive technique.
It is still another object of the invention to provide an allograft implant which has load bearing capabilities.
It is further an object of the invention to provide an allograft implant procedure which is applicable for both partial and full thickness lesions.
It is yet another object of the invention to provide an allograft implant which facilitates growth of hyaline cartilage.
It is an additional object of the invention to provide a cancellous construct which is treated with chondrogenic stimulating factors.
These and other objects, advantages, and novel features of the present invention will become apparent when considered with the teachings contained in the detailed disclosure along with the
accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows the anatomy of a knee joint;
Figure 2 shows a schematic mosaicplasty as known in the prior art;
Figure 3 shows an exploded perspective view of the inventive two piece cancellous construct;
Figure 4 shows a top plan view of the two piece allograft cancellous construct assembly showing the blind bore and plurality of through going bores in phantom;
Figure 5 shows a side elevation view of the two piece construct shown in Figure 4;
Figure 6 is a side elevation view of the two piece construct of Figure 4 turned 90 ° with the blind and parallel bores shown in phantom;
Figure 7 shows a perspective view of the base member of the cancellous construct with the cap member removed;
Figure 8 shows a perspective view of the cap member of the cancellous construct;
Figure 9 is a side elevation view of the cap member shown in Figure 8; and
Figure 10 is a side elevation view of the cap member of the construct of Figure 9 turned 90°.
DESCRIPTION OF THE INVENTION
The term "tissue" is used in the general sense herein to mean any transplantable or implantable tissue, the survivability of which is improved by the methods described herein upon implantation, In particular, the overall durability and longevity of the implant are improved, and host-immune system mediated responses, are substantially eliminated.
The terms "transplant" and "implant" are used interchangeably to refer to tissue, material or cells (xenogeneic or allogeneic) which may be introduced into the body of a patient.
The terms "autologous" and "autograft" refer to tissue or cells which originate with or are derived from the recipient, whereas the terms "allogeneic" and "allograft" refer to cells and tissue which originate with or are derived from a donor of the same species as the recipient. The terms "xenogeneic" and "xenograft" refer to cells or tissue which originates with or are derived from a
species other than that of the recipient.
The present invention is directed towards a cartilage repair construct constructed of two separate pieces of allograft cancellous bone.
Both pieces of the two-piece allograft construct are to be derived from dense cancellous bone that may originate from proximal or distal femur, proximal or distal tibia, proximal humerus, talus, calceneus, patella, or iliium. Cancellous tissue is first processed into blocks and then milled into the desired shapes. The top piece or cap member is substantially demineralized in dilute acid until the bone contains less than 0.2% wt/wt residual calcium. Subsequently, the resultant tissue form is predominantly Type I collagen, which is sponge-like in nature with an elastic quality. Following decalcification, the tissue is further cleaned and may also be treated so that the cancellous tissue is non-osteoinductive. This inactivation of inherent osteoinductivity may be accomplished via chemical or thermal treatment or by high energy irradiation. In a preferred embodiment, the cancellous cap member is treated with an oxidizing agent such as hydrogen peroxide in order to achieve a non-osteoinductive material. The bottom piece will be formed from mineralized cancellous bone or partially demineralized cancellous bone.
The two piece allograft cancellous construct 20 has a base member 22 with a cap member 30 which is held fixed in place in the base member by a pin 40. The base member 22 is preferably constructed of mineralized cancellous bone and is shaped in the form of a cylinder for easy insertion into bores cut into the patient to cut away cartilage defect areas. However, the base member 22 may be surface or partially demineralized or contain a region of cortical bone so that it is cortical/cancellous. The body of the base member 22 defines a blind bore 23 which holds the stem 36 of the cap member 30. The bottom surface 24 of the blind bore as seen in Figures 5-7 has a plurality of longitudinal through going bores 25 extending through the base member 22 and ending on the distal end surface 26 of the base member which is preferably planar. The top surface 27 of the base member 22 is also preferably planar forming a seat for the cap member 30. A transverse bore 28 extends through the diameter of the cylindrical base above the bottom surface 24 of the blind bore 23 and intersects the blind bore 23. A second plurality of through going bores 29 are circumferentially positioned around the blind bore 23 parallel to the central axis of the base member
22 and extend from the top surface 27 to the bottom surface 26. The through going bores 25 and 29 have a smaller diameter than the blind bore 23 with a diameter ranging from 0.5 to 2.0 mm
The cap member 30 has a cylindrical top section 32 which has a thickness of about 3mm with a top planar surface 33, an outer curved wall 34 and a bottom planar surface 35 which is seated adjacent the top surface 27 of the base member 22 when the components are mounted together. The top surface 33 while preferably planar may be milled to a degree of curvature that makes the implant construct match the physiological curvature in the knee. Larger constructs may have a cap member that has multiple stem sections and a base with an inverse "female" pattern which receives the stem sections. An integral cylindrical stem 36 extends away from the bottom planar surface 35 a length which is not longer than the depth of the blind bore 23 and has a diameter equal to or less than the diameter of the blind bore 23. The stem 36 defines a transverse through going bore 37 which is aligned with transverse bore 28 of the base member to receive a cylindrical pin 40 which is inserted radially through the construct to hold the cap member 30 in place within the base member 22. The cap member 30 is preferably formed of demineralized cancellous allograft bone with a calcium content less than of 0.2 % calcium or has a substantially demineralized region such as the entire top section with a calcium content less than 0.2% calcium. The cylindrical pin 40 is preferably constructed of cortical bone and has a length equal to or less than the diameter of the base member 22. The pin can also be constructed of a synthetic material.
The cap member 30 can be secured to the base member 22 by a staple, suture, press fit or an adhesive compound such as fibrin based glue.
The construct 20 is placed in a defect area bore which has been cut in the lesion area of the bone of a patient with the upper surface 26 of the cap member 30 being slightly proud, slightly below, or substantially flush with the surface of the original cartilage remaining at the area being treated. The construct 20 has a length which can be the same as the depth of the defect or more or less than the depth of the bore. If the construct 20 is the same as the depth of the bore 60, the base of the implant is supported by the bottom surface of the bore and the top surface 33 of cap 30 is substantially level with the articular cartilage. If the construct 20 is of a lesser length, the base of the construct is not supported but support is provided by the wall of the defect area bore or respective cut out area as the plug is interference fit within the bore or cut out area with the cap being slightly
proud, slightly below, or flush with the surrounding articular cartilage depending on the surgeon's preference. With such load bearing support the graft surface is not damaged by weight or bearing loads which can cause micromotion interfering with the graft interface producing fibrous tissue interfaces and subchondral cysts.
If desired, a plurality of through going bores 25 and 29 in the construct allow cell migration throughout the construct to promote cartilage growth in the cartilage area and bone growth in the adjacent bore region.
In operation, the lesion or defect is removed by cutting a bore removing a lesion in the implant area. If desired, the open cancellous structure of the cap member 30 may be loaded with a cartilage paste or gel as noted below and/or one or more additives namely recombinant or native growth factors (FGF-2, FGF-5, FGF-7, IGF-1, TGF-β, BMP-2, BMP-4, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic cells, human allogenic or autologous bone marrow cells, human allogenic or autologous stem cells, demineralized bone matrix, insulin, insulin-like growth factor-1, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet- derived growth factor, Indian hedgehog parathyroid hormone-related peptide, viral vectors for growth factor or DNA delivery, nanoparticles, or platelet-rich plasma. The construct 20 is then placed in the bore or cut away area in an interface fit with the surrounding walls.
If the construct is moveable within the bore, suitable organic glue material can be used to keep the implant fixed in place in the implant area. Suitable organic glue material can be found commercially, such as for example; TISSEEL® or TISSUCOL .® (fibrin based adhesive; Immuno AG, Austria), Adhesive Protein ( Sigma Chemical, USA), Dow Corning Medical Adhesive B (Dow Corning, USA), fibrinogen thrombin, elastin, collagen, casein, albumin, keratin and the like.
The base of the blind bore 33 of the construct can alternatively be provided with a matrix of minced cartilage putty or gel consisting of minced or milled allograft cartilage which has been lyophilized so that its water content ranges from 0.1 % to 8.0% ranging from 25% to 50% by weight, mixed with a carrier of sodium hyaluronate solution (HA) (molecular weight ranging from 7.0x 105 to 1.2 x 106) or any other bioabsorbable carrier such as hyaluronic acid and its derivatives, gelatin, collagen, chitosan, alginate, buffered PBS, Dextran, or polymers, the carrier ranging from ranging from 75% to 50% by weight. The cartilage is milled to a size ranging up to 1 mm.
In the gel form, the minced cartilage has been lyophilized so that its water content ranges from 0.1 % to 8.0%, ranging from 15% to 30% by weight and the carrier ranges from 85% to 70% by weight. The particle size of the cartilage when milled is less than or equal to 1 mm dry. The cartilage pieces can be processed to varying particle sizes and the HA or other carrier can have different viscosities depending on the desired consistency of the putty or gel. This cartilage matrix can be deposited into the matrix of the demineralized cap member. The putty or gel enhances the tissue integration between the plug and host tissue.
It is also envisioned that demineralized bone matrix and/or growth factors such as (FGF-2, FGF-5, FGF-7, IGF-1, TGF-β, BMP-2, BMP-4, BMP-7, PDGF, VEGF) or soluble factors such as insulin, interleukin- 1 receptor antagonist, hepatocyte growth factor, Indian hedgehog and parathyroid hormone-related peptide, viral vectors for growth factor or DNA delivery, nanoparticles may be adsorbed or combined with the scaffold or the cartilage fragments. In another embodiment, platelet- rich plasma may be added to the scaffold.
It is also envisioned that cells which have been grown outside the patient can be inserted by syringe into the cancellous cap matrix before, during or after deposit of the construct 20 into the defect area. Such cells include allogenic or autologous, bone marrow cells, stem cells and chondrocyte cells. The cellular density of the cells preferably ranges from 1.0 x 108 to 5.0 x 108 or from about 100 million to about 500 million cells per cc of putty or gel mixture. This matrix can support the previously mentioned chondrogenic stimulating factors.
The principles, preferred embodiments and modes of operation of the present invention have been described in the foregoing specification. However, the invention should not be construed as limited to the particular embodiments which have been described above. Instead, the embodiments described here should be regarded as illustrative rather than restrictive. Variations and changes may be made by others without departing from the scope of the present invention as defined by the following claims:
Claims
1. A cartilage repair assembly for repair of a defect in articular cartilage comprising an allograft bone base member and a cancellous allograft bone cap member mounted to said base member, said cap member possessing at least one substantially demineralized region.
2. A cartilage repair assembly for repair of a defect in articular cartilage comprising a sterile mineralized allograft bone base member defining an axial bore and a through going bore intersecting said axial bore, a demineralized cancellous allograft bone cap member mounted to said base member in said axial bore, said cap member being treated to be non-osteoinducti ve, said cap member defining a through going bore which is adapted to be aligned with said base member through going bore, said allograft bone base member being sized to have an interference fit in a cut away opening in a cartilage defect area and fastening means inserted through said base member and cap member hold the same in a fixed relationship.
3. A cartilage repair assembly as claimed in claim 2 wherein said mineralized allograft bone base member is cylindrically shaped.
4. A cartilage repair assembly as claimed in claim 2 wherein said allograft bone base member axial bore is a blind bore with at least one through going bore running from the base of said blind bore to the distal end of the base member.
5. A cartilage repair assembly as claimed in claim 2 wherein said allograft bone base member has a plurality of through going bores running the length of the base member.
6. A cartilage repair assembly as claimed in claim 2 wherein said cap member comprises a top disc shaped section and a stem extending from said top disc shaped section.
7. A cartilage repair assembly as claimed in claim 6 wherein said stem defines a through going bore running transverse the axis of the stem.
8. A cartilage repair assembly as claimed in claim 6 wherein said cap member top section is cylindrical and is about 3mm in thickness.
9. A cartilage repair assembly as claimed in claim 5 wherein said plurality of through going bores run parallel to the center axis of the base member.
10. A cartilage repair assembly as claimed in claim 2 wherein said cap member is demineralized to a calcium content of less than 0.2 percent and treated to remove osteoinductivity.
1 1. A cartilage repair assembly as claimed in claim 9 wherein said bores have a diameter ranging from about 0.5mm to about 2.0mm.
12. A cartilage repair assembly as claimed in claim 2 wherein said fastening means is a cylindrical pin member mounted in said base member bore and said cap member through going bore.
13. A cartilage repair assembly as claimed in claim 2 wherein said fastening means is constructed of allograft cortical bone.
14. A cartilage repair assembly as claimed in claim 6 wherein said cap member top section has a top surface is milled to a degree of curvature that matches the physiological curvature of the cartilage area being repaired.
15. A cartilage repair assembly as claimed in claim 2 wherein said cap member contains milled cartilage pieces and a carrier.
16. A cartilage repair assembly as claimed in claim 2 wherein said cap member contains one or more additives taken from a group consisting of growth factors(FGF-2, FGF-5, FGF-7, IGF-1 , TGF- β, BMP-2, BMP-4, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin- like growth factor- 1, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog and parathyroid hormone-related peptide or bioactive glue.
17. A cartilage repair assembly as claimed in claim 2 wherein on the top section of said cap member is demineralized to a residual calcium content less than 0.2%.
18. A cartilage repair assembly as claimed in claim 2 wherein said cap member is constructed with a disc shaped section having at least a top portion non-osteoinductive and a cylindrical shaped stem section extending from said disc shaped section.
19. A cartilage repair assembly for repair of a defect in articular cartilage comprising a cylindrical sterile mineralized allograft bone base member defining a blind bore and a through going bore communicating with said blind bore and positioned transverse to a central axis of said cylindrical base member, an allograft cancellous bone cap member demineralized to have a calcium content of less than 0.2 percent and treated to remove osteoinducti vity mounted in said base member blind bore, said cap member including an extended stem which defines a through going bore which can be aligned with said base member through going bore, said allograft bone base member being sized to have an interference fit in a drilled bore in a cartilage defect area and cylindrical pin member mounted in said base member through going bore and said cap member stem through going bore.
20. A cartilage repair assembly for repair of a defect in articular cartilage comprising a sterile mineralized allograft bone base member defining a blind bore, a transverse through going bore intersecting said blind bore, a plurality of through going bores running through said base member parallel to a central axis of the base member and a demineralized cancellous allograft bone cap member mounted to said base member, said cap member being treated to remove osteoinductivity, said cap member defining a through going bore which can be aligned with said bore member bone cartilage cap, said allograft bone base member being sized to have an interference fit in a drilled bore in a cartilage defect area.
21. A cartilage repair assembly as claimed in claim 20 wherein said cap member is demineralized so that it has a calcium content less than 0.2 percent
22. A cartilage repair assembly as claimed in claim 20 wherein said cartilage repair assembly is cylindrically shaped.
23. A cartilage repair assembly as claimed in claim 20 wherein said cap member contains one or more additives taken from a group consisting of growth factors(FGF-2, FGF-5, FGF-7, IGF-1 , TGF- β, BMP-2, BMP-4, BMP-7, PDGF, VEGF), human allogenic or autologous chondrocytes, human allogenic or autologous bone marrow cells, stem cells, demineralized bone matrix, insulin, insulin- like growth factor- 1, transforming growth factor-B, interleukin-1 receptor antagonist, hepatocyte growth factor, platelet-derived growth factor, Indian hedgehog and parathyroid hormone-related peptide or bioactive glue.
24. A cartilage repair assembly as claimed in claim 20 wherein said cap member has a top surface that is curved to match the physiological curvature of the cartilage area being replaced.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08782728A EP2162094A2 (en) | 2007-01-24 | 2008-01-23 | Two piece cancellous construct for cartilage repair |
CA2675170A CA2675170C (en) | 2007-01-24 | 2008-01-23 | Two piece cancellous construct for cartilage repair |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/657,042 | 2007-01-24 | ||
US11/657,042 US7837740B2 (en) | 2007-01-24 | 2007-01-24 | Two piece cancellous construct for cartilage repair |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008106254A2 true WO2008106254A2 (en) | 2008-09-04 |
WO2008106254A3 WO2008106254A3 (en) | 2009-07-30 |
Family
ID=39721812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/051796 WO2008106254A2 (en) | 2007-01-24 | 2008-01-23 | Two piece cancellous construct for cartilage repair |
Country Status (4)
Country | Link |
---|---|
US (2) | US7837740B2 (en) |
EP (1) | EP2162094A2 (en) |
CA (1) | CA2675170C (en) |
WO (1) | WO2008106254A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009111069A1 (en) * | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
WO2010083051A3 (en) * | 2009-01-15 | 2010-09-23 | ProChon Biotech, Ltd. | Cartilage particle tissue mixtures optionally combined with a cancellous construct |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
USRE42208E1 (en) | 2003-04-29 | 2011-03-08 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
US8497121B2 (en) | 2006-12-20 | 2013-07-30 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
US8518433B2 (en) | 2003-12-11 | 2013-08-27 | Zimmer, Inc. | Method of treating an osteochondral defect |
US8702809B2 (en) | 2007-09-14 | 2014-04-22 | Purdue Research Foundation | Demineralized cancellous bone scaffolds |
US9138318B2 (en) | 2007-04-12 | 2015-09-22 | Zimmer, Inc. | Apparatus for forming an implant |
US9701940B2 (en) | 2005-09-19 | 2017-07-11 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
US10167447B2 (en) | 2012-12-21 | 2019-01-01 | Zimmer, Inc. | Supports and methods for promoting integration of cartilage tissue explants |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8563232B2 (en) | 2000-09-12 | 2013-10-22 | Lifenet Health | Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced |
US20090024224A1 (en) | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
US8685432B2 (en) * | 2008-03-25 | 2014-04-01 | University Of Utah Research Foundation | Controlled release tissue graft combination biomaterials |
BRPI0914950A2 (en) * | 2008-06-19 | 2015-10-20 | Synthes Gmbh | implants, systems and techniques for increasing the mechanical advantage of bone screws |
US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
US10610364B2 (en) * | 2008-12-04 | 2020-04-07 | Subchondral Solutions, Inc. | Method for ameliorating joint conditions and diseases and preventing bone hypertrophy |
NL2002742C2 (en) * | 2009-04-09 | 2010-10-12 | Univ Delft Tech | Mechanical device for tissue regeneration. |
WO2011031637A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
WO2011031642A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
US8864768B2 (en) | 2009-11-20 | 2014-10-21 | Zimmer Knee Creations, Inc. | Coordinate mapping system for joint treatment |
CN102740789A (en) | 2009-11-20 | 2012-10-17 | 膝部创造物有限责任公司 | Instruments for targeting a joint defect |
US8801800B2 (en) | 2009-11-20 | 2014-08-12 | Zimmer Knee Creations, Inc. | Bone-derived implantable devices and tool for subchondral treatment of joint pain |
KR20120101079A (en) | 2009-11-20 | 2012-09-12 | 니 크리에이션스, 엘엘씨 | Instruments for a variable angle approach to a joint |
US8608802B2 (en) | 2009-11-20 | 2013-12-17 | Zimmer Knee Creations, Inc. | Implantable devices for subchondral treatment of joint pain |
WO2011063281A1 (en) | 2009-11-20 | 2011-05-26 | Knee Creations, Llc | Navigation and positioning instruments for joint repair |
US8951261B2 (en) | 2009-11-20 | 2015-02-10 | Zimmer Knee Creations, Inc. | Subchondral treatment of joint pain |
US8821504B2 (en) | 2009-11-20 | 2014-09-02 | Zimmer Knee Creations, Inc. | Method for treating joint pain and associated instruments |
US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
WO2012097506A1 (en) * | 2011-01-19 | 2012-07-26 | 北京大学第三医院 | Matrix for repairing and regenerating articular cartilage and method for preparing the matrix |
WO2012154950A2 (en) * | 2011-05-10 | 2012-11-15 | Board Of Regents, University Of Texas System | Cortical bone scaffold for guided osteon regeneration in load-bearing orthopaedic applications |
US8920511B2 (en) | 2011-11-17 | 2014-12-30 | Allosource | Multi-piece machine graft systems and methods |
US10172651B2 (en) | 2012-10-25 | 2019-01-08 | Warsaw Orthopedic, Inc. | Cortical bone implant |
US9265609B2 (en) | 2013-01-08 | 2016-02-23 | Warsaw Orthopedic, Inc. | Osteograft implant |
EP2953581B1 (en) | 2013-02-05 | 2020-09-16 | University of Utah Research Foundation | Implantable devices for bone or joint defects |
KR102215401B1 (en) | 2013-02-22 | 2021-02-10 | 알로소스 | Cartilage mosaic compositions and methods |
US9289452B2 (en) | 2013-03-07 | 2016-03-22 | Allosource | Consistent calcium content bone allograft systems and methods |
KR102312720B1 (en) | 2013-03-15 | 2021-10-13 | 알로소스 | Cell repopulated collagen matrix for soft tissue repair and regeneration |
WO2014151939A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Perforated osteochondral allograft compositions |
US9730796B2 (en) | 2014-05-16 | 2017-08-15 | Allosource | Composite bone constructs and methods |
US11666447B1 (en) * | 2015-03-05 | 2023-06-06 | Taq Ortho, LLC | Bone implant augment and offset device |
US20170056190A1 (en) * | 2015-08-27 | 2017-03-02 | Wright Medical Technology, Inc. | Subtalar biofoam wedge |
CN117771029A (en) * | 2015-10-05 | 2024-03-29 | 孚美公司 | Medical implant and fixation system for a medical implant |
CN114587492A (en) | 2015-11-25 | 2022-06-07 | 软骨解决方案股份有限公司 | Implantable orthopedic device |
EP3645066A1 (en) | 2017-06-30 | 2020-05-06 | Allosource | Cellular bone grafts, and methods of manufacture and use |
US10786370B2 (en) | 2017-12-28 | 2020-09-29 | Industrial Technology Research Institute | Cartilage repair implant, auxiliary surgical tool kit and cartilage repair system |
CN112704588B (en) * | 2020-12-21 | 2022-07-29 | 济宁医学院附属医院 | Individualized customization articular cartilage damage prosthetic devices based on 3D prints |
US11883302B2 (en) | 2021-11-22 | 2024-01-30 | Warsaw Orthopedic, Inc. | Spinal implant having a compressible insert |
CN117398220B (en) * | 2023-12-13 | 2024-04-02 | 北京爱康宜诚医疗器材有限公司 | Cartilage repair prosthesis |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4627853A (en) * | 1985-05-29 | 1986-12-09 | American Hospital Supply Corporation | Method of producing prostheses for replacement of articular cartilage and prostheses so produced |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6306174B1 (en) * | 1998-12-18 | 2001-10-23 | Benoist Girard Sas | Femoral component |
US20020120274A1 (en) * | 2001-02-26 | 2002-08-29 | Ethicon, Inc. | Tissue scaffold anchor for cartilage repair |
US6454811B1 (en) * | 1998-10-12 | 2002-09-24 | Massachusetts Institute Of Technology | Composites for tissue regeneration and methods of manufacture thereof |
US20040102850A1 (en) * | 2002-11-25 | 2004-05-27 | Shepard Yolanda Denise | Cortical and cancellous allograft spacer |
US20040193268A1 (en) * | 2003-03-31 | 2004-09-30 | Hazebrouck Stephen A. | Intercalary prosthesis, kit and method |
US20040230303A1 (en) * | 2003-05-16 | 2004-11-18 | Gomes Katherine A. | Cartilage allograft plug |
US20050209705A1 (en) * | 2004-03-09 | 2005-09-22 | Niederauer Gabriele G | Implant scaffold combined with autologous or allogenic tissue |
US20060235534A1 (en) * | 2005-04-15 | 2006-10-19 | Gertzman Arthur A | Vertebral disc repair |
Family Cites Families (529)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3400199A (en) | 1965-02-26 | 1968-09-03 | Leslie L. Balassa | Wound-healing cartilage powder |
US3478145A (en) * | 1964-09-15 | 1969-11-11 | American Home Prod | Chromatographic purification of virus with brushite modified by autoclaving |
US3476855A (en) * | 1965-02-26 | 1969-11-04 | Leslie L Balassa | Sterilizing and enhancing activity of a finely divided cartilage powder |
US3551560A (en) | 1967-10-02 | 1970-12-29 | Heinrich F Thiele | Process of reconstructing tendons,cartilage,nerve sheaths,and products |
US3772432A (en) | 1971-01-11 | 1973-11-13 | Lescarden Ltd | Cartilage compositions for dental use |
CA992255A (en) | 1971-01-25 | 1976-07-06 | Cutter Laboratories | Prosthesis for spinal repair |
US3966908A (en) * | 1973-11-29 | 1976-06-29 | Lescarden Ltd. | Method of treating degenerative joint afflictions |
US4172128A (en) | 1975-03-26 | 1979-10-23 | Erhard Thiele | Process of degrading and regenerating bone and tooth material and products |
US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
US4201845A (en) | 1976-04-12 | 1980-05-06 | Monsanto Company | Cell culture reactor |
US4296100A (en) | 1980-06-30 | 1981-10-20 | Franco Wayne P | Method of treating the heart for myocardial infarction |
US4378347A (en) | 1980-06-30 | 1983-03-29 | Franco Wayne P | Composition for treating the heart for myocardial infarction |
US4400833A (en) | 1981-06-10 | 1983-08-30 | Kurland Kenneth Z | Means and method of implanting bioprosthetics |
US4442655A (en) | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
AT369990B (en) | 1981-07-28 | 1983-02-25 | Immuno Ag | METHOD FOR PRODUCING A TISSUE ADHESIVE |
US4394370A (en) | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
US4479271A (en) | 1981-10-26 | 1984-10-30 | Zimmer, Inc. | Prosthetic device adapted to promote bone/tissue ingrowth |
US4458678A (en) | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4505266A (en) | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
JPS5891755A (en) * | 1981-11-26 | 1983-05-31 | Sunstar Giken Kk | Epoxy resin composition and its preparation |
US4501269A (en) | 1981-12-11 | 1985-02-26 | Washington State University Research Foundation, Inc. | Process for fusing bone joints |
IL68218A (en) | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
US4801299A (en) | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
US4932973A (en) | 1983-09-30 | 1990-06-12 | El Gendler | Cartilage and bone induction by artificially perforated organic bone matrix |
US5155214A (en) | 1984-03-05 | 1992-10-13 | The Salk Institute For Biological Studies | Basic fibroblast growth factor |
US4609551A (en) * | 1984-03-20 | 1986-09-02 | Arnold Caplan | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
US4600574A (en) | 1984-03-21 | 1986-07-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of producing a tissue adhesive |
US4757017A (en) | 1984-09-14 | 1988-07-12 | Mcw Research Foundation, Inc. | In vitro cell culture system |
CH665348A5 (en) | 1985-01-09 | 1988-05-13 | Sulzer Ag | IMPLANTS. |
CH665770A5 (en) | 1985-01-25 | 1988-06-15 | Sulzer Ag | PLASTIC BONE IMPLANT. |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
CA1260391A (en) | 1985-03-28 | 1989-09-26 | Karl A. Piez | Xenogeneic collagen/mineral preparations in bone repair |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5053049A (en) | 1985-05-29 | 1991-10-01 | Baxter International | Flexible prostheses of predetermined shapes and process for making same |
US4681763A (en) | 1985-06-11 | 1987-07-21 | University Of Medicine And Dentistry Of New Jersey | Composition for stimulating bone growth |
US5266476A (en) | 1985-06-18 | 1993-11-30 | Yeda Research & Development Co., Ltd. | Fibrous matrix for in vitro cell cultivation |
IL76079A (en) | 1985-08-13 | 1991-03-10 | Univ Ramot | Collagen implants |
US4656137A (en) | 1985-09-12 | 1987-04-07 | Lescarden Inc | Method of processing animal cartilage |
US5859208A (en) | 1988-07-06 | 1999-01-12 | Fiddes; John C. | Human basic fibroblast growth factor analog |
US5604293A (en) | 1985-09-12 | 1997-02-18 | Scios Inc. | Recombinant human basic fibroblast growth factor |
US5439818A (en) | 1985-09-12 | 1995-08-08 | Scios Nova Inc. | DNA encoding human recombinant basic fibroblast growth factor |
US4994559A (en) | 1985-12-17 | 1991-02-19 | Synergen, Inc. | Human basic fibroblast growth factor |
US4776173A (en) | 1985-12-20 | 1988-10-11 | Angio-Medical Corporation | Method for extracting a substance from animal derived material |
US6005161A (en) | 1986-01-28 | 1999-12-21 | Thm Biomedical, Inc. | Method and device for reconstruction of articular cartilage |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
SU1454423A1 (en) | 1986-06-27 | 1989-01-30 | Киевский Медицинский Институт Им.Акад.А.А.Богомольца | Method of recovery of articular surface of cystic condyles of the femur in case of rheumatoid arthritis |
GB8618374D0 (en) | 1986-07-28 | 1986-09-03 | Hsc Res Dev Corp | Biological vascular prostheses |
FI80605C (en) | 1986-11-03 | 1990-07-10 | Biocon Oy | Bone surgical biocomposite material |
US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
US5041138A (en) | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
GB8708009D0 (en) * | 1987-04-03 | 1987-05-07 | Clayton Found Res | Injectable soft tissue augmentation materials |
US4846835A (en) | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
US4880429A (en) | 1987-07-20 | 1989-11-14 | Stone Kevin R | Prosthetic meniscus |
US5681353A (en) * | 1987-07-20 | 1997-10-28 | Regen Biologics, Inc. | Meniscal augmentation device |
US5007934A (en) | 1987-07-20 | 1991-04-16 | Regen Corporation | Prosthetic meniscus |
US5306311A (en) | 1987-07-20 | 1994-04-26 | Regen Corporation | Prosthetic articular cartilage |
US5260420A (en) | 1987-07-30 | 1993-11-09 | Centre Regional De Transfusion Sanguine De Lille | Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
US4950296A (en) | 1988-04-07 | 1990-08-21 | Mcintyre Jonathan L | Bone grafting units |
US5354557A (en) | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
CH674139A5 (en) | 1988-04-21 | 1990-05-15 | Sulzer Ag | |
US4904259A (en) | 1988-04-29 | 1990-02-27 | Samuel Itay | Compositions and methods for repair of cartilage and bone |
US5053050A (en) | 1988-04-29 | 1991-10-01 | Samuel Itay | Compositions for repair of cartilage and bone |
US4837379A (en) | 1988-06-02 | 1989-06-06 | Organogenesis Inc. | Fibrin-collagen tissue equivalents and methods for preparation thereof |
US5496722A (en) | 1988-06-30 | 1996-03-05 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method for producing non-neoplastic, three dimensional, mammalian tissue and cell aggregates under microgravity culture conditions and the products produced therefrom |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
DE3826915A1 (en) | 1988-08-09 | 1990-02-15 | Henkel Kgaa | NEW MATERIALS FOR BONE REPLACEMENT AND BONE OR PROSTHESIS COMPOSITION |
US5649904A (en) * | 1988-10-07 | 1997-07-22 | Sandoz Ltd. | Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both |
US4971954A (en) | 1988-11-23 | 1990-11-20 | University Of Medicine And Dentistry Of New Jersey | Collagen-based matrices ribose cross-linked |
US4963146A (en) | 1989-04-20 | 1990-10-16 | Colla-Tec Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration |
US5191067A (en) | 1989-04-27 | 1993-03-02 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
US5576288A (en) | 1989-04-27 | 1996-11-19 | The Salk Institute For Biological Studies | Fibroblast growth factor conjugates |
US4994084A (en) | 1989-06-23 | 1991-02-19 | Brennan H George | Reconstructive surgery method and implant |
US5290558A (en) | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5073373A (en) | 1989-09-21 | 1991-12-17 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5236456A (en) | 1989-11-09 | 1993-08-17 | Osteotech, Inc. | Osteogenic composition and implant containing same |
US5152791A (en) | 1989-12-07 | 1992-10-06 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
US5067964A (en) | 1989-12-13 | 1991-11-26 | Stryker Corporation | Articular surface repair |
US5118512A (en) | 1990-01-23 | 1992-06-02 | Osteotech, Inc. (A Delaware Corp.) | Process for cryopreserving biological materials and materials prepared thereby |
US5425769A (en) | 1990-04-23 | 1995-06-20 | Snyders, Jr.; Robert V. | Composition of material for osseous repair |
FR2664808A1 (en) | 1990-07-23 | 1992-01-24 | Gersberg Eduardo | System of dental implants |
US5067963A (en) * | 1990-08-21 | 1991-11-26 | Washington University | Method of making live autogenous skeletal replacement parts |
US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
ES2076467T3 (en) | 1990-10-31 | 1995-11-01 | El Gendler | FLEXIBLE MEMBRANES PRODUCED WITH ORGANIC BONE MATTER FOR THE REPAIR AND RECONSTRUCTION OF PARTS OF THE SKELETON. |
US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
DK0486862T3 (en) | 1990-11-23 | 1996-06-24 | American Cyanamid Co | Chimeric fibrolast growth factor |
US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
US5206023A (en) | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5853746A (en) | 1991-01-31 | 1998-12-29 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
US5312456A (en) | 1991-01-31 | 1994-05-17 | Carnegie Mellon University | Micromechanical barb and method for making the same |
JP3385040B2 (en) | 1991-02-14 | 2003-03-10 | 武田薬品工業株式会社 | Glial activator and method for producing the same |
US5192312A (en) | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
DE4215137A1 (en) | 1991-06-04 | 1992-12-10 | Man Ceramics Gmbh | IMPLANT FOR SPINE PILLARS |
SE9101853D0 (en) | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | IMPROVED TISSUE ASHESIVE |
US6440427B1 (en) | 1991-06-17 | 2002-08-27 | Biovitrum Ab | Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
DE4120325A1 (en) | 1991-06-20 | 1992-12-24 | Merck Patent Gmbh | IMPLANT MATERIAL |
US5356629A (en) | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
US6503277B2 (en) | 1991-08-12 | 2003-01-07 | Peter M. Bonutti | Method of transplanting human body tissue |
US5092887A (en) * | 1991-08-12 | 1992-03-03 | El Gendler | Artificial ligament produced from demineralized bone for the replacement and augmentation of ligaments, tendons and other fibrous connective tissue |
US5329846A (en) | 1991-08-12 | 1994-07-19 | Bonutti Peter M | Tissue press and system |
US5270300A (en) | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
US5261422A (en) * | 1991-10-29 | 1993-11-16 | Kelly Michael P | Acoustic administration of remedies process and device |
US5284155A (en) | 1991-12-06 | 1994-02-08 | The General Hospital Corporation | Cartilage degradation assay system |
US5513662A (en) | 1991-12-31 | 1996-05-07 | Osteotech, Inc. | Preparation of bone for transplantation |
US5314476A (en) * | 1992-02-04 | 1994-05-24 | Osteotech, Inc. | Demineralized bone particles and flowable osteogenic composition containing same |
US5876452A (en) | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
EP0625891B1 (en) | 1992-02-14 | 1997-01-08 | Board Of Regents The University Of Texas System | Multi-phase bioerodible implant/carrier and method of manufacturing and using same |
EP0626868A1 (en) | 1992-02-19 | 1994-12-07 | EBERLIN, Jean-Luc | Collagen- and fibrin adhesive-based graft for osteocartilaginous reconstruction, and preparation method therefor |
US5326357A (en) | 1992-03-18 | 1994-07-05 | Mount Sinai Hospital Corporation | Reconstituted cartridge tissue |
GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
US5256140A (en) | 1992-03-27 | 1993-10-26 | Fallien Cosmeceuticals, Ltd. | Composition for levelling skin |
AU3930793A (en) * | 1992-05-08 | 1993-12-13 | Apple Computer, Inc. | Textured sphere and spherical environment map rendering using texture map double indirection |
EP0656939B1 (en) | 1992-08-07 | 2004-03-31 | TEI Biosciences, Inc. | Production of graft tissue from extracellular matrix |
US5800537A (en) | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
US5195791A (en) * | 1992-08-13 | 1993-03-23 | Hu Chiu S | Portable security buckle for doors |
US5352463A (en) | 1992-11-13 | 1994-10-04 | Badylak Steven F | Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
EP0608546A3 (en) | 1992-12-22 | 1995-09-27 | Takeda Chemical Industries Ltd | Glia activating factor (gaf), antibodies against it and their uses. |
US5549904A (en) | 1993-06-03 | 1996-08-27 | Orthogene, Inc. | Biological adhesive composition and method of promoting adhesion between tissue surfaces |
US5380328A (en) | 1993-08-09 | 1995-01-10 | Timesh, Inc. | Composite perforated implant structures |
US5491220A (en) | 1993-09-24 | 1996-02-13 | Yeda Research And Development Co., Ltd. | Surface loop structural analogues of fibroblast growth factors |
US5507813A (en) | 1993-12-09 | 1996-04-16 | Osteotech, Inc. | Shaped materials derived from elongate bone particles |
US5411885A (en) | 1993-12-17 | 1995-05-02 | New York Blood Center, Inc. | Methods for tissue embedding and tissue culturing |
CA2184916C (en) | 1994-03-08 | 2008-05-13 | Colin R. Dunstan | Use of fibroblast growth factors to stimulate bone growth |
US5656598A (en) | 1994-03-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Use of fibroblast growth factors to stimulate bone growth |
ES2219660T3 (en) | 1994-03-14 | 2004-12-01 | Cryolife, Inc | METHODS OF PREPARATION OF FABRICS FOR IMPLEMENTATION. |
JP2896235B2 (en) | 1994-03-18 | 1999-05-31 | バクスター、インターナショナル、インコーポレイテッド | Topical fibrinogen complex |
US5916265A (en) | 1994-03-30 | 1999-06-29 | Hu; Jie | Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant |
US5618925A (en) * | 1994-04-28 | 1997-04-08 | Les Laboratories Aeterna Inc. | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
US6025334A (en) | 1994-04-28 | 2000-02-15 | Les Laboratoires Aeterna Inc. | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
US5723331A (en) | 1994-05-05 | 1998-03-03 | Genzyme Corporation | Methods and compositions for the repair of articular cartilage defects in mammals |
US7963997B2 (en) | 2002-07-19 | 2011-06-21 | Kensey Nash Corporation | Device for regeneration of articular cartilage and other tissue |
US5906827A (en) | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
IL110367A (en) | 1994-07-19 | 2007-05-15 | Colbar Lifescience Ltd | Collagen-based matrix |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5769899A (en) | 1994-08-12 | 1998-06-23 | Matrix Biotechnologies, Inc. | Cartilage repair unit |
US5632745A (en) | 1995-02-07 | 1997-05-27 | R&D Biologicals, Inc. | Surgical implantation of cartilage repair unit |
US5707962A (en) | 1994-09-28 | 1998-01-13 | Gensci Regeneration Sciences Inc. | Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof |
TW369414B (en) | 1994-09-30 | 1999-09-11 | Yamanouchi Pharma Co Ltd | Bone formation transplant |
US5919892A (en) * | 1994-10-31 | 1999-07-06 | The Dow Chemical Company | Polyamic acids and methods to convert polyamic acids into polyimidebenzoxazole films |
US20010011131A1 (en) | 1997-07-28 | 2001-08-02 | Luyten Frank P. | DNA molecules encoding cartilage-derived morphogenetic proteins |
US5891558A (en) | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
US5709934A (en) | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
US6599515B1 (en) | 1995-01-16 | 2003-07-29 | Baxter International Inc. | Fibrin porous structure |
ATE244584T1 (en) | 1995-01-16 | 2003-07-15 | Baxter Int | SELF-SUPPORTING SURFACES MADE OF CROSS-LINKED FIBRIN FOR INHIBITING POSTOPERATIVE ADHESIONS |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5749874A (en) | 1995-02-07 | 1998-05-12 | Matrix Biotechnologies, Inc. | Cartilage repair unit and method of assembling same |
US5713374A (en) | 1995-02-10 | 1998-02-03 | The Hospital For Joint Diseases Orthopaedic Institute | Fixation method for the attachment of wound repair materials to cartilage defects |
US6080194A (en) | 1995-02-10 | 2000-06-27 | The Hospital For Joint Disease Orthopaedic Institute | Multi-stage collagen-based template or implant for use in the repair of cartilage lesions |
US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
GB9721585D0 (en) | 1997-10-10 | 1997-12-10 | Geistlich Soehne Ag | Chemical product |
US20030039695A1 (en) | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
US7141072B2 (en) | 1998-10-05 | 2006-11-28 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering |
US5782835A (en) | 1995-03-07 | 1998-07-21 | Innovasive Devices, Inc. | Apparatus and methods for articular cartilage defect repair |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
EP0821573A4 (en) | 1995-04-19 | 2000-08-09 | St Jude Medical | Matrix substrate for a viable body tissue-derived prosthesis and method for making the same |
US5904716A (en) | 1995-04-26 | 1999-05-18 | Gendler; El | Method for reconstituting cartilage tissue using demineralized bone and product thereof |
US6060640A (en) | 1995-05-19 | 2000-05-09 | Baxter International Inc. | Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue |
US5674292A (en) * | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
US6039762A (en) | 1995-06-07 | 2000-03-21 | Sdgi Holdings, Inc. | Reinforced bone graft substitutes |
US5782915A (en) | 1995-09-15 | 1998-07-21 | Stone; Kevin R. | Articular cartilage heterografts |
ATE192779T1 (en) | 1995-10-06 | 2000-05-15 | Microcloning Cccd Ab | COMPACT CELL CULTURE DISK |
US5716413A (en) | 1995-10-11 | 1998-02-10 | Osteobiologics, Inc. | Moldable, hand-shapable biodegradable implant material |
US5989289A (en) | 1995-10-16 | 1999-11-23 | Sdgi Holdings, Inc. | Bone grafts |
US20020111695A1 (en) | 1995-11-06 | 2002-08-15 | Mount Sinai Hospital Corporation | Reconstituted mineralized cartilage tissue |
US5788626A (en) * | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
IL116477A (en) | 1995-12-21 | 2000-02-29 | Hadasit Med Res Service | Bone graft substitute and process for producing same |
US5814084A (en) | 1996-01-16 | 1998-09-29 | University Of Florida Tissue Bank, Inc. | Diaphysial cortical dowel |
US5964724A (en) | 1996-01-31 | 1999-10-12 | Medtronic Electromedics, Inc. | Apparatus and method for blood separation |
US5842477A (en) | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
US6352558B1 (en) | 1996-02-22 | 2002-03-05 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damage joint |
US6221854B1 (en) | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
US5700774A (en) | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
US5755791A (en) * | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
WO1997040137A1 (en) | 1996-04-19 | 1997-10-30 | Osiris Therapeutics, Inc. | Regeneration and augmentation of bone using mesenchymal stem cells |
EP0922093B1 (en) | 1996-06-04 | 2003-09-24 | Sulzer Orthopedics Ltd. | Method for making cartilage and implants |
US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US6666892B2 (en) | 1996-08-23 | 2003-12-23 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
US5989269A (en) | 1996-08-30 | 1999-11-23 | Vts Holdings L.L.C. | Method, instruments and kit for autologous transplantation |
US6569172B2 (en) | 1996-08-30 | 2003-05-27 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US5759190A (en) | 1996-08-30 | 1998-06-02 | Vts Holdings Limited | Method and kit for autologous transplantation |
US6189537B1 (en) | 1996-09-06 | 2001-02-20 | Lifenet | Process for producing osteoinductive bone, and osteoinductive bone produced thereby |
US5881733A (en) * | 1996-09-13 | 1999-03-16 | Depuy Orthopaedic Technology, Inc. | Technique for osteocartilaginous transplantation in a mammalian joint |
US5964805A (en) | 1997-02-12 | 1999-10-12 | Stone; Kevin R. | Method and paste for articular cartilage transplantation |
EP0929322A1 (en) | 1996-09-30 | 1999-07-21 | Children's Medical Center Corporation | Methods and compositions for programming an organic matrix for remodeling into a target tissue |
US6165487A (en) | 1996-09-30 | 2000-12-26 | Children's Medical Center Corporation | Methods and compositions for programming an organic matrix for remodeling into a target tissue |
US6884871B2 (en) * | 1996-10-11 | 2005-04-26 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and use of tissue growth-inducing Frzb protein |
EP2264175B1 (en) | 1996-10-16 | 2012-11-21 | ZymoGenetics, Inc. | Fibroblast growth factor homologs |
AU732421B2 (en) | 1996-10-23 | 2001-04-26 | Warsaw Orthopedic, Inc. | Spinal spacer |
US5974663A (en) | 1996-10-25 | 1999-11-02 | Honda Giken Kogya Kabushiki Kaisha | Method of manufacturing connecting rod |
WO1998019719A1 (en) | 1996-11-05 | 1998-05-14 | Purdue Research Foundation | Myocardial graft constructs |
EP1230902A1 (en) | 1996-11-15 | 2002-08-14 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
DE19647853A1 (en) | 1996-11-19 | 1998-05-20 | Bioph Biotech Entw Pharm Gmbh | Compounds with improved cartilage and / or bone inducing activity |
US5728159A (en) | 1997-01-02 | 1998-03-17 | Musculoskeletal Transplant Foundation | Serrated bone graft |
US7468075B2 (en) | 2001-05-25 | 2008-12-23 | Conformis, Inc. | Methods and compositions for articular repair |
US8545569B2 (en) | 2001-05-25 | 2013-10-01 | Conformis, Inc. | Patient selectable knee arthroplasty devices |
US5866165A (en) | 1997-01-15 | 1999-02-02 | Orquest, Inc. | Collagen-polysaccharide matrix for bone and cartilage repair |
AU6267798A (en) | 1997-02-07 | 1998-08-26 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
US6146385A (en) | 1997-02-11 | 2000-11-14 | Smith & Nephew, Inc. | Repairing cartilage |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
US5866415A (en) | 1997-03-25 | 1999-02-02 | Villeneuve; Peter E. | Materials for healing cartilage and bone defects |
US6001352A (en) | 1997-03-31 | 1999-12-14 | Osteobiologics, Inc. | Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor |
GB2348426B (en) | 1997-04-03 | 2001-06-27 | California Inst Of Techn | Enzyme-mediated modification of fibrin for tissue engineering |
AU742613B2 (en) | 1997-04-04 | 2002-01-10 | Barnes-Jewish Hospital | Neocartilage and methods of use |
ATE412383T1 (en) | 1997-05-30 | 2008-11-15 | Osteobiologics Inc | FIBER REINFORCED POROUS BIODEGRADABLE IMPLANT DEVICE |
US7524335B2 (en) | 1997-05-30 | 2009-04-28 | Smith & Nephew, Inc. | Fiber-reinforced, porous, biodegradable implant device |
US5972368A (en) | 1997-06-11 | 1999-10-26 | Sdgi Holdings, Inc. | Bone graft composites and spacers |
CN1161127C (en) | 1997-07-03 | 2004-08-11 | 奥奎斯特公司 | Cross-linked polysaccharide drug carrier |
US5910315A (en) | 1997-07-18 | 1999-06-08 | Stevenson; Sharon | Allograft tissue material for filling spinal fusion cages or related surgical spaces |
WO1999009149A1 (en) | 1997-08-01 | 1999-02-25 | Massachusetts Institute Of Technology | Three-dimensional polymer matrices |
US6090996A (en) | 1997-08-04 | 2000-07-18 | Collagen Matrix, Inc. | Implant matrix |
US6110209A (en) | 1997-08-07 | 2000-08-29 | Stone; Kevin R. | Method and paste for articular cartilage transplantation |
US6511958B1 (en) | 1997-08-14 | 2003-01-28 | Sulzer Biologics, Inc. | Compositions for regeneration and repair of cartilage lesions |
EP0896825B1 (en) | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
US7048762B1 (en) | 1997-08-27 | 2006-05-23 | Regeneration Technologies, Inc. | Elongated cortical bone implant |
US20010031254A1 (en) | 1998-11-13 | 2001-10-18 | Bianchi John R. | Assembled implant |
WO1999009914A1 (en) | 1997-08-27 | 1999-03-04 | University Of Florida Tissue Bank, Inc. | Cortical bone cervical smith-robinson fusion implant |
US20020138143A1 (en) | 1997-08-27 | 2002-09-26 | Grooms Jamie M. | Cortical bone cervical Smith-Robinson fusion implant |
US6309659B1 (en) | 1997-09-02 | 2001-10-30 | Gensci Orthobiologics, Inc. | Reverse phase connective tissue repair composition |
US6077987A (en) | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
AT407117B (en) | 1997-09-19 | 2000-12-27 | Immuno Ag | FIBRINE SPONGE |
US5998170A (en) | 1997-10-03 | 1999-12-07 | Amgen Inc. | Polynucleotides encoding hepatocyte-specific members of the FGF family |
WO1999021497A1 (en) | 1997-10-27 | 1999-05-06 | Sulzer Orthopädie Ag | Method and instruments for repairing endochondral and osteochondral defects |
US6652592B1 (en) | 1997-10-27 | 2003-11-25 | Regeneration Technologies, Inc. | Segmentally demineralized bone implant |
US6090998A (en) | 1997-10-27 | 2000-07-18 | University Of Florida | Segmentally demineralized bone implant |
US20030099620A1 (en) | 1997-10-30 | 2003-05-29 | The General Hospital Corporation | Bonding of cartilaginous matrices using isolated chondrocytes |
EP0949298B1 (en) | 1997-10-30 | 2005-01-12 | EC-Showa Denko K.K. | Composite resin composition |
WO1999022747A1 (en) | 1997-10-30 | 1999-05-14 | The General Hospital Corporation | Bonding of cartilaginous matrices using isolated chondrocytes |
US6197586B1 (en) | 1997-12-12 | 2001-03-06 | The Regents Of The University Of California | Chondrocyte-like cells useful for tissue engineering and methods |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
US5899939A (en) | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US6712851B1 (en) | 1998-01-23 | 2004-03-30 | Macropore Biosurgery, Inc. | Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
DE19803673A1 (en) | 1998-01-30 | 1999-08-05 | Norbert M Dr Meenen | Biohybrid joint replacement |
US7087082B2 (en) | 1998-08-03 | 2006-08-08 | Synthes (Usa) | Bone implants with central chambers |
US6123731A (en) | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US6326018B1 (en) * | 1998-02-27 | 2001-12-04 | Musculoskeletal Transplant Foundation | Flexible sheet of demineralized bone |
US6030635A (en) | 1998-02-27 | 2000-02-29 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
USRE38522E1 (en) * | 1998-02-27 | 2004-05-25 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
US6458375B1 (en) | 1998-02-27 | 2002-10-01 | Musculoskeletal Transplant Foundation | Malleable paste with allograft bone reinforcement for filling bone defects |
US7045141B2 (en) | 1998-02-27 | 2006-05-16 | Musculoskeletal Transplant Foundation | Allograft bone composition having a gelatin binder |
US7019192B2 (en) | 1998-02-27 | 2006-03-28 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
US6056777A (en) * | 1998-02-27 | 2000-05-02 | Mcdowell; Charles L. | Method and device for regenerating cartilage in articulating |
US6437018B1 (en) | 1998-02-27 | 2002-08-20 | Musculoskeletal Transplant Foundation | Malleable paste with high molecular weight buffered carrier for filling bone defects |
US6911212B2 (en) | 1998-02-27 | 2005-06-28 | Musculoskeletal Transplant Foundation | Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects |
US6143293A (en) | 1998-03-26 | 2000-11-07 | Carnegie Mellon | Assembled scaffolds for three dimensional cell culturing and tissue generation |
US20040044408A1 (en) | 1998-04-08 | 2004-03-04 | Hungerford David S. | Cell-culture and polymer constructs |
CA2330972C (en) | 1998-05-01 | 2008-08-19 | Zymogenetics, Inc. | Fully recombinant tissue sealant compositions |
US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
US6293970B1 (en) | 1998-06-30 | 2001-09-25 | Lifenet | Plasticized bone and soft tissue grafts and methods of making and using same |
US6734018B2 (en) | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
US20080077251A1 (en) | 1999-06-07 | 2008-03-27 | Chen Silvia S | Cleaning and devitalization of cartilage |
WO2000002905A2 (en) | 1998-07-13 | 2000-01-20 | University Of Southern California | Methods for accelerating bone and cartilage growth and repair |
US6274090B1 (en) | 1998-08-05 | 2001-08-14 | Thermogenesis Corp. | Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
EP1102568A1 (en) | 1998-08-06 | 2001-05-30 | SDGI Holdings, Inc. | Composited intervertebral bone spacers |
AU771701B2 (en) | 1998-08-14 | 2004-04-01 | Genzyme Corporation | Methods, instruments and materials for chondrocyte cell transplantation |
US6849255B2 (en) * | 1998-08-18 | 2005-02-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for enhancing cartilage repair |
US6530956B1 (en) | 1998-09-10 | 2003-03-11 | Kevin A. Mansmann | Resorbable scaffolds to promote cartilage regeneration |
US6582960B1 (en) | 1998-09-18 | 2003-06-24 | Massachusetts Institute Of Technology | Use of fibroblast growth factor 2 for expansion of chondrocytes and tissue engineering |
JP2002527402A (en) | 1998-10-14 | 2002-08-27 | オークエスト インコーポレイテッド | A method for inducing or enhancing cartilage formation with an extracellular matrix containing GDF-5. |
US6174311B1 (en) | 1998-10-28 | 2001-01-16 | Sdgi Holdings, Inc. | Interbody fusion grafts and instrumentation |
DE19851334C2 (en) | 1998-11-06 | 2000-09-28 | Aventis Behring Gmbh | Flexible fibrin-based wound dressing and process for its manufacture |
US6497726B1 (en) | 2000-01-11 | 2002-12-24 | Regeneration Technologies, Inc. | Materials and methods for improved bone tendon bone transplantation |
US6761887B1 (en) | 1998-11-16 | 2004-07-13 | Osiris Therapeutics, Inc. | Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells |
US6165486A (en) | 1998-11-19 | 2000-12-26 | Carnegie Mellon University | Biocompatible compositions and methods of using same |
US6025538A (en) | 1998-11-20 | 2000-02-15 | Musculoskeletal Transplant Foundation | Compound bone structure fabricated from allograft tissue |
US20020165611A1 (en) | 1998-12-22 | 2002-11-07 | Robert-Jan Enzerink | Graft material convenience package |
US6200347B1 (en) | 1999-01-05 | 2001-03-13 | Lifenet | Composite bone graft, method of making and using same |
US6547823B2 (en) | 1999-01-22 | 2003-04-15 | Osteotech, Inc. | Intervertebral implant |
US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
AU772682B2 (en) | 1999-02-04 | 2004-05-06 | Warsaw Orthopedic, Inc. | Highly-mineralized osteogenic sponge compositions, and uses thereof |
US6267786B1 (en) | 1999-02-11 | 2001-07-31 | Crosscart, Inc. | Proteoglycan-reduced soft tissue xenografts |
WO2000047114A1 (en) | 1999-02-12 | 2000-08-17 | Collagenesis, Inc. | Injectable collagen-based delivery system for bone morphogenic proteins |
US6696073B2 (en) | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6197061B1 (en) * | 1999-03-01 | 2001-03-06 | Koichi Masuda | In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
US6662805B2 (en) | 1999-03-24 | 2003-12-16 | The Johns Hopkins University | Method for composite cell-based implants |
EP1093390B1 (en) | 1999-04-12 | 2013-05-08 | Harvest Technologies Corporation | Method and apparatus for producing platelet rich plasma and/or platelet concentrate |
US7338524B2 (en) | 1999-05-10 | 2008-03-04 | Fell Barry M | Surgically implantable knee prosthesis |
US7297161B2 (en) | 1999-05-10 | 2007-11-20 | Fell Barry M | Surgically implantable knee prosthesis |
GB9912240D0 (en) | 1999-05-27 | 1999-07-28 | Smith & Nephew | Implantable medical devices |
US6251143B1 (en) | 1999-06-04 | 2001-06-26 | Depuy Orthopaedics, Inc. | Cartilage repair unit |
US6288043B1 (en) * | 1999-06-18 | 2001-09-11 | Orquest, Inc. | Injectable hyaluronate-sulfated polysaccharide conjugates |
US6333029B1 (en) | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US6652872B2 (en) | 1999-07-06 | 2003-11-25 | Ramat At Tel Aviv University Ltd. | Scaffold formed of tissue treated to eliminate cellular and cytosolic elements |
US7056885B1 (en) | 1999-07-27 | 2006-06-06 | Curagen Corporation | Fibroblast growth factor and nucleic acids encoding same |
US7078232B2 (en) | 1999-08-19 | 2006-07-18 | Artecel, Inc. | Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof |
US6429013B1 (en) | 1999-08-19 | 2002-08-06 | Artecel Science, Inc. | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
FR2798671A1 (en) * | 1999-09-16 | 2001-03-23 | Univ Paris Curie | CHONDROCYTE COMPOSITIONS, PREPARATION AND USES |
US7687462B2 (en) | 1999-10-05 | 2010-03-30 | The Regents Of The University Of California | Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition |
EP1099443A1 (en) | 1999-11-11 | 2001-05-16 | Sulzer Orthopedics Ltd. | Transplant/implant device and method for its production |
WO2001038357A2 (en) | 1999-11-22 | 2001-05-31 | Millennium Pharmaceuticals, Inc. | Jaffa, a novel fibroblast growth factor family member and uses therefor |
DE19957388A1 (en) | 1999-11-24 | 2001-06-13 | Michael Sittinger | Chondroinductive and implantable substrates for cartilage healing and protection |
DE19958007A1 (en) * | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Injection molding process for (meth) acrylate copolymers with tertiary ammonium groups |
ATE539157T1 (en) | 1999-12-02 | 2012-01-15 | Zymogenetics Inc | METHODS THAT TARGET CELLS EXPRESSING THE FIBROBLAS GROWTH FACTOR RECEPTORS-3 OR -2 |
ATE423517T1 (en) | 1999-12-03 | 2009-03-15 | Univ Leeds | RESTORATION OF DAMAGED TISSUE |
ES2230170T3 (en) | 1999-12-15 | 2005-05-01 | Zimmer Gmbh | PREPARATION FOR THE REPAIR OF ARTICLES IN MAN OR ANIMAL, AS A CONSEQUENCE OF CARTILAGINOUS OR CARTILAGINO-OSEAS ANOMALIES. |
US6623963B1 (en) | 1999-12-20 | 2003-09-23 | Verigen Ag | Cellular matrix |
US6576265B1 (en) | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
US6579538B1 (en) * | 1999-12-22 | 2003-06-17 | Acell, Inc. | Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof |
EP1248844B8 (en) | 1999-12-22 | 2006-10-25 | Ortho-McNeil Pharmaceutical, Inc. | Analogs of human basic fibroblast growth factor |
US6376244B1 (en) | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
WO2001049333A2 (en) | 1999-12-30 | 2001-07-12 | Osteotech, Inc. | Methods for manufacturing skeletal implants |
US6379385B1 (en) | 2000-01-06 | 2002-04-30 | Tutogen Medical Gmbh | Implant of bone matter |
US6893462B2 (en) | 2000-01-11 | 2005-05-17 | Regeneration Technologies, Inc. | Soft and calcified tissue implants |
WO2001078798A1 (en) | 2000-02-10 | 2001-10-25 | Regeneration Technologies, Inc. | Assembled implant |
US7182781B1 (en) | 2000-03-02 | 2007-02-27 | Regeneration Technologies, Inc. | Cervical tapered dowel |
US6371958B1 (en) * | 2000-03-02 | 2002-04-16 | Ethicon, Inc. | Scaffold fixation device for use in articular cartilage repair |
US6591581B2 (en) | 2000-03-08 | 2003-07-15 | Arthrex, Inc. | Method for preparing and inserting round, size specific osteochondral cores in the knee |
US6626945B2 (en) | 2000-03-14 | 2003-09-30 | Chondrosite, Llc | Cartilage repair plug |
AR027685A1 (en) | 2000-03-22 | 2003-04-09 | Synthes Ag | METHOD AND METHOD FOR CARRYING OUT |
DK1265630T3 (en) | 2000-03-24 | 2006-10-09 | Genentech Inc | Use of insulin for the treatment of cartilage disease |
EP1142596A1 (en) | 2000-04-03 | 2001-10-10 | Universiteit Gent | Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants |
US6932977B2 (en) | 2000-04-14 | 2005-08-23 | Depuy Spine, Inc. | Method of inducing or enhancing chondrogenesis with extracellular matrix containing BMP-4 |
US6520964B2 (en) * | 2000-05-01 | 2003-02-18 | Std Manufacturing, Inc. | System and method for joint resurface repair |
US6993328B1 (en) | 2000-05-08 | 2006-01-31 | Nokia Corporation | Method for over the air mobile station management |
US7108721B2 (en) | 2000-05-11 | 2006-09-19 | Massachusetts Institute Of Technology | Tissue regrafting |
EP1280564B1 (en) | 2000-05-12 | 2005-08-31 | Osteotech, Inc. | Surface demineralized osteoimplant and method for making same |
US6488033B1 (en) | 2000-05-15 | 2002-12-03 | Cryolife, Inc. | Osteochondral transplant techniques |
US6686184B1 (en) | 2000-05-25 | 2004-02-03 | President And Fellows Of Harvard College | Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks |
MXPA03000203A (en) | 2000-06-29 | 2004-09-13 | Biosyntech Canada Inc | Composition and method for the repair and regeneration of cartilage and other tissues. |
TR200400527T4 (en) | 2000-07-03 | 2004-07-21 | Osteotech Inc. | Bone-derived osteogenic implants |
US7018416B2 (en) | 2000-07-06 | 2006-03-28 | Zimmer Spine, Inc. | Bone implants and methods |
US9387094B2 (en) | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
DK177997B1 (en) | 2000-07-19 | 2015-02-23 | Ed Geistlich Söhne Ag Für Chemische Ind | Bone material and collagen combination for healing of damaged joints |
WO2002007748A2 (en) | 2000-07-20 | 2002-01-31 | The Board Of Regents, The University Of Texas System | Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
US6440141B1 (en) | 2000-07-24 | 2002-08-27 | Oratec Interventions, Inc. | Method and apparatus for treating osteochondral pathologies |
US9452238B2 (en) | 2000-07-29 | 2016-09-27 | Smith & Nephew LLP | Tissue implant |
US8366787B2 (en) | 2000-08-04 | 2013-02-05 | Depuy Products, Inc. | Hybrid biologic-synthetic bioabsorbable scaffolds |
DE10042484A1 (en) | 2000-08-29 | 2002-03-28 | Merck Patent Gmbh | Preparing human cartilage implants, useful for repairing damaged joints, comprises culturing autologous chondrocytes in alginate gel at reduced oxygen partial pressure |
WO2002018546A2 (en) | 2000-09-01 | 2002-03-07 | Virginia Commonwealth University Intellectual Property Foundation | Plasma-derived-fibrin-based matrices and tissue |
IL138529A0 (en) | 2000-09-18 | 2003-09-17 | Yeda Res & Dev | High level expression of heterologous proteins |
US6432436B1 (en) | 2000-10-03 | 2002-08-13 | Musculoskeletal Transplant Foundation | Partially demineralized cortical bone constructs |
US7548865B2 (en) * | 2000-10-20 | 2009-06-16 | Arthrex, Inc. | Method of selling procedure specific allografts and associated instrumentation |
IL139380A0 (en) | 2000-10-31 | 2001-11-25 | Prochon Biotech Ltd | Active variants of fibroblast growth factor |
EP1341484B1 (en) * | 2000-12-08 | 2009-05-06 | Osteotech, Inc. | Implant for orthopedic applications |
CA2365376C (en) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
WO2002053193A2 (en) | 2001-01-02 | 2002-07-11 | The Charles Stark Draper Laboratory, Inc. | Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology |
US6838440B2 (en) | 2001-01-24 | 2005-01-04 | Collagen Nutraceuticals, Inc. | Kolla2-desiccated avian sternal cartilage powder |
EP1377661A4 (en) | 2001-01-30 | 2009-10-21 | Orthogene Inc | Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
EP1383549A1 (en) | 2001-02-14 | 2004-01-28 | Osteotech, Inc. | Implant derived from bone |
WO2002098332A1 (en) | 2001-02-16 | 2002-12-12 | Sulzer Spine-Tech Inc. | Bone implants and methods |
US20030050709A1 (en) | 2001-02-23 | 2003-03-13 | Ulrich Noth | Trabecular bone-derived human mesenchymal stem cells |
US6575986B2 (en) | 2001-02-26 | 2003-06-10 | Ethicon, Inc. | Scaffold fixation device for use in articular cartilage repair |
US6855169B2 (en) | 2001-02-28 | 2005-02-15 | Synthes (Usa) | Demineralized bone-derived implants |
IL141813A (en) | 2001-03-05 | 2010-04-15 | Hadasit Med Res Service | Mixture comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the preparation of compositions for the treatment of hematopoietic dusirders |
US6995013B2 (en) | 2002-07-08 | 2006-02-07 | Biomed Solutions, Llc | Cell-scaffold composition containing five layers |
US7252982B2 (en) | 2001-03-15 | 2007-08-07 | Massachusetts Institute Of Technology | Tissue engineering enhanced by the transfer of a growth factor gene |
US20040151705A1 (en) | 2002-03-22 | 2004-08-05 | Shuichi Mizuno | Neo-cartilage constructs and a method for preparation thereof |
WO2002076285A2 (en) | 2001-03-23 | 2002-10-03 | Histogenics Corporation | Composition and methods fro the production of biological tissues and tissue constructs |
WO2002077199A2 (en) | 2001-03-27 | 2002-10-03 | Massachusetts Institute Of Technology | Methods and products related to fgf dimerization |
MXPA03010616A (en) | 2001-05-21 | 2004-04-02 | Omrix Biopharm Sa | Removal of plasmin(ogen) from protein solutions. |
DE60239674D1 (en) | 2001-05-25 | 2011-05-19 | Conformis Inc | METHOD AND COMPOSITIONS FOR REPAIRING THE SURFACE OF JOINTS |
GB0115320D0 (en) * | 2001-06-22 | 2001-08-15 | Univ Nottingham | Matrix |
US6626950B2 (en) * | 2001-06-28 | 2003-09-30 | Ethicon, Inc. | Composite scaffold with post anchor for the repair and regeneration of tissue |
US6824547B2 (en) | 2001-07-13 | 2004-11-30 | Pilling Weck Incorporated | Endoscopic clip applier and method |
JP4294474B2 (en) | 2001-07-16 | 2009-07-15 | デピュイ・プロダクツ・インコーポレイテッド | Meniscus reproduction device |
AU2002316696B2 (en) | 2001-07-16 | 2007-08-30 | Depuy Products, Inc. | Cartilage repair and regeneration scaffold and method |
DE60239342D1 (en) | 2001-07-16 | 2011-04-14 | Depuy Products Inc | DEVICE FOR THE REPAIR OF CARTILING MATERIAL |
AU2002316694B2 (en) | 2001-07-16 | 2007-09-06 | Depuy Products, Inc. | Hybrid biologic/synthetic porous extracellular matrix scaffolds |
EP1416879A4 (en) | 2001-07-16 | 2007-04-25 | Depuy Products Inc | Unitary surgical device and method |
US7201917B2 (en) | 2001-07-16 | 2007-04-10 | Depuy Products, Inc. | Porous delivery scaffold and method |
US8025896B2 (en) | 2001-07-16 | 2011-09-27 | Depuy Products, Inc. | Porous extracellular matrix scaffold and method |
US8337537B2 (en) | 2001-07-16 | 2012-12-25 | Depuy Products, Inc. | Device from naturally occurring biologically derived materials |
US7819918B2 (en) | 2001-07-16 | 2010-10-26 | Depuy Products, Inc. | Implantable tissue repair device |
IL144446A0 (en) | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
AU2002355844A1 (en) | 2001-08-01 | 2003-02-17 | New York University | Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis |
US8178123B2 (en) | 2001-08-29 | 2012-05-15 | Femina Pharma Incorporated | Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration |
US7132110B2 (en) | 2001-08-30 | 2006-11-07 | Isotis Orthobiologics, Inc. | Tissue repair compositions and methods for their manufacture and use |
WO2003024463A1 (en) * | 2001-09-15 | 2003-03-27 | Rush-Presbyterian-St. Luke's Medical Center | Stratified cartilage tissue and methods to engineer same |
US6855167B2 (en) | 2001-12-05 | 2005-02-15 | Osteotech, Inc. | Spinal intervertebral implant, interconnections for such implant and processes for making |
US7252987B2 (en) | 2001-12-06 | 2007-08-07 | Islet Technology, Inc. | System for analysis and selection of encapsulated cellular materials |
CA2474269A1 (en) | 2002-01-23 | 2003-07-31 | Institute Of Nutraceutical Research Pty Ltd | Nutraceuticals for the treatment, protection and restoration of connective tissues |
US6852331B2 (en) | 2002-02-11 | 2005-02-08 | Taipei Biotechnology Ltd., Inc. | Fabrication of a cartilage implant |
US6890354B2 (en) | 2002-03-08 | 2005-05-10 | Musculoskeletal Transplant Foundation | Bone-tendon-bone assembly with allograft bone block and method for inserting same |
US20030175410A1 (en) | 2002-03-18 | 2003-09-18 | Campbell Phil G. | Method and apparatus for preparing biomimetic scaffold |
US7468192B2 (en) | 2002-03-22 | 2008-12-23 | Histogenics Corporation | Method for repair of cartilage lesions |
US7537780B2 (en) | 2002-03-22 | 2009-05-26 | Histogenics Corporation | Method for preparing and implanting a cartilage construct to treat cartilage lesions |
NL1020426C2 (en) | 2002-04-18 | 2003-10-21 | Tno | Modification of the properties of a fibrin matrix with respect to cell growth and ingrowth. |
CN1665458A (en) | 2002-05-01 | 2005-09-07 | 维里根股份公司 | Injectable chondrocyte implant |
IL149562A0 (en) | 2002-05-09 | 2002-11-10 | Prochon Ltd | Fgf variants and methods for use thereof |
WO2003094987A1 (en) | 2002-05-13 | 2003-11-20 | Toshiba Ceramics Co.,Ltd | Member for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and aritficial cartilage for transplantation |
US7931687B2 (en) | 2002-05-13 | 2011-04-26 | Articular Engineering, Llc | Tissue engineered osteochondral implant |
US7338492B2 (en) | 2002-05-15 | 2008-03-04 | Linvatec Corporation | Cross-pin graft fixation, instruments, and methods |
US6989034B2 (en) | 2002-05-31 | 2006-01-24 | Ethicon, Inc. | Attachment of absorbable tissue scaffolds to fixation devices |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US7291179B2 (en) | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
US20040166169A1 (en) | 2002-07-15 | 2004-08-26 | Prasanna Malaviya | Porous extracellular matrix scaffold and method |
US7264634B2 (en) | 2002-09-20 | 2007-09-04 | Arthrex, Inc. | Method and instrumentation for osteochondral repair using preformed implants |
US20040062753A1 (en) | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US7323011B2 (en) | 2002-10-18 | 2008-01-29 | Musculoskeletal Transplant Foundation | Cortical and cancellous allograft cervical fusion block |
US7824701B2 (en) * | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
AT500418B1 (en) | 2002-12-05 | 2009-12-15 | Winkler Heinz Dr | CULTIVATED CELLULAR CELLS CONTAINING THE IMPLANT AND METHOD FOR THE PRODUCTION THEREOF |
CA2514474C (en) | 2003-01-30 | 2014-05-06 | Avner Yayon | Freeze-dried fibrin matrices and methods for preparation thereof |
US7985414B2 (en) | 2003-02-04 | 2011-07-26 | Warsaw Orthopedic, Inc. | Polyurethanes for osteoimplants |
EP1444995A1 (en) | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | FGF-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
US20060178748A1 (en) | 2004-02-05 | 2006-08-10 | Dinger Fred B Iii | Implants and delivery system for treating defects in articulating surfaces |
AU2004216551B2 (en) | 2003-02-26 | 2008-09-18 | Zimmer Orthobiologics, Inc. | Preparation for repairing cartilage tissue, especially articular cartilage defects |
US7642092B2 (en) | 2003-03-03 | 2010-01-05 | Technion Research & Development Foundation Ltd. | Cultured cartilage/bone cells/tissue, method of generating same and uses thereof |
US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US20050064042A1 (en) | 2003-04-29 | 2005-03-24 | Musculoskeletal Transplant Foundation | Cartilage implant plug with fibrin glue and method for implantation |
US20050222687A1 (en) | 2004-04-02 | 2005-10-06 | Gordana Vunjak-Novakovic | Cartilage implant assembly and method for implantation |
US7488348B2 (en) | 2003-05-16 | 2009-02-10 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US20090291112A1 (en) | 2003-05-16 | 2009-11-26 | Truncale Katherine G | Allograft osteochondral plug combined with cartilage particle mixture |
US7537617B2 (en) | 2003-06-05 | 2009-05-26 | Warsaw Orthopedic, Inc. | Bone strip implants and method of making same |
US20070067032A1 (en) | 2003-06-27 | 2007-03-22 | Felt Jeffrey C | Meniscus preserving implant method and apparatus |
EP1651050B1 (en) | 2003-07-21 | 2012-08-22 | Lifecell Corporation | Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue |
WO2005011765A1 (en) | 2003-07-31 | 2005-02-10 | Yukihide Iwamoto | Method of constructing artificial joint |
CA2533124C (en) | 2003-08-12 | 2014-01-28 | Tigenix N.V. | Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
US7217294B2 (en) | 2003-08-20 | 2007-05-15 | Histogenics Corp. | Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof |
EP1662973A4 (en) | 2003-08-20 | 2011-07-20 | Histogenics Corp | Acellular matrix implanted into an articular cartilage or osteochondral lesion protected with a biodegradable polymer modified to have extended polymerization time and methods for preparation and use thereof |
US7226482B2 (en) | 2003-09-02 | 2007-06-05 | Synthes (U.S.A.) | Multipiece allograft implant |
KR101226811B1 (en) | 2003-09-05 | 2013-01-28 | 신세스 게엠바하 | Bone cement compositions having fiber-reinforcement and/or increased flowability |
US20050065613A1 (en) * | 2003-09-24 | 2005-03-24 | Gross Jeffrey M. | Reinforced fusion implant |
US7763459B2 (en) | 2003-10-02 | 2010-07-27 | Depuy Spine, Inc. | Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
US20050074476A1 (en) | 2003-10-03 | 2005-04-07 | El Gendler | Cartilidge and bone induction by artificially perforated organic bone matrix augmented by undifferentiated cells suspended in bone gel |
EP1526760A1 (en) | 2003-10-21 | 2005-04-27 | IEE INTERNATIONAL ELECTRONICS & ENGINEERING S.A. | Multiple electroluminescent lamp driver |
GB0325141D0 (en) | 2003-10-28 | 2003-12-03 | Xiros Plc | Repair of damaged tissue on a bone site |
EP1686923A1 (en) * | 2003-11-18 | 2006-08-09 | Quantum Orthopedics | Osteoconductive integrated spinal cage and method of making same |
US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
US7157428B2 (en) | 2003-11-26 | 2007-01-02 | Histogenics, Corp. | Method for treatment and repair of meniscal injuries |
US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
US7666230B2 (en) | 2003-12-08 | 2010-02-23 | Depuy Products, Inc. | Implant device for cartilage regeneration in load bearing articulation regions |
ES2404682T3 (en) | 2003-12-11 | 2013-05-28 | Isto Technologies Inc. | Particle Cartilage System |
US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
US20050196460A1 (en) | 2004-03-08 | 2005-09-08 | Malinin Theodore I. | Particulate cartilage compositions, processes for their preparation and methods for regenerating cartilage |
US20070185585A1 (en) | 2004-03-09 | 2007-08-09 | Brat Bracy | Implant Scaffold Combined With Autologous Tissue, Allogenic Tissue, Cultured Tissue, or combinations Thereof |
US7648965B2 (en) | 2004-05-14 | 2010-01-19 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
US7531518B2 (en) | 2004-05-14 | 2009-05-12 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
ES2245879B1 (en) | 2004-05-21 | 2006-12-16 | Universidad De Malaga | COMPOSITION FOR OSEA OR CARTILAGINOUS REPAIR. |
US20050288796A1 (en) | 2004-06-23 | 2005-12-29 | Hani Awad | Native soft tissue matrix for therapeutic applications |
US7406210B2 (en) | 2004-06-28 | 2008-07-29 | Xerox Corporation | Darkness control using pattern matching |
US7335508B2 (en) | 2004-07-22 | 2008-02-26 | Prochon Biotech Ltd. | Porous plasma protein matrices and methods for preparation thereof |
WO2006023803A2 (en) | 2004-08-20 | 2006-03-02 | Artes Medical, Inc. | Methods of administering microparticles combined with autologous body components |
EP1796690A4 (en) | 2004-09-22 | 2011-08-03 | Cartilix Inc | Cartilage filling device |
US8043315B2 (en) | 2004-09-23 | 2011-10-25 | Arthrex, Inc. | Osteochondral repair using plug fashioned from partial distal allograft femur or condyle |
US7273756B2 (en) | 2004-10-01 | 2007-09-25 | Isto Technologies, Inc. | Method for chondrocyte expansion with phenotype retention |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US20080220044A1 (en) | 2007-03-06 | 2008-09-11 | Semler Eric J | Cancellous construct with support ring for repair of osteochondral defects |
US20060111778A1 (en) | 2004-10-29 | 2006-05-25 | Michalow Alexander E | Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway |
SE0403020D0 (en) | 2004-12-13 | 2004-12-13 | Rickard Braanemark | Implant |
AU2006210847A1 (en) | 2005-02-01 | 2006-08-10 | Osteobiologics, Inc. | Method and device for selective addition of a bioactive agent to a multi-phase implant |
US7621963B2 (en) | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
US7291169B2 (en) | 2005-04-15 | 2007-11-06 | Zimmer Technology, Inc. | Cartilage implant |
US8506646B2 (en) | 2005-04-29 | 2013-08-13 | Warsaw Orthopedic, Inc. | Multi-purpose medical implant devices |
US20060247790A1 (en) | 2005-04-30 | 2006-11-02 | Mckay William F | Shaped osteochondral grafts and methods of using same |
WO2006121612A1 (en) | 2005-05-05 | 2006-11-16 | Isto Technologies, Inc. | Treatment of joint disease, methods and apparatuses therefor |
US8092548B2 (en) * | 2005-06-22 | 2012-01-10 | Warsaw Orthopedic, Inc. | Osteograft treatment to promote osteoinduction and osteograft incorporation |
US20070010824A1 (en) | 2005-07-11 | 2007-01-11 | Hugues Malandain | Products, systems and methods for delivering material to bone and other internal body parts |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
US7622438B1 (en) | 2005-07-18 | 2009-11-24 | Acologix, Inc. | Protein formulation for promoting hard tissue formation |
US20070026030A1 (en) | 2005-07-27 | 2007-02-01 | Berkeley Advanced Biomaterials, Inc. | Method of preparing rheological materials for bone and cartilage repair |
AU2006282754A1 (en) | 2005-08-26 | 2007-03-01 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of joint disease |
US7927630B2 (en) | 2005-09-12 | 2011-04-19 | Johnson Lanny L | Use of autologous sediment from fluid aspirates as vehicles for drug delivery |
EP1926459B1 (en) | 2005-09-19 | 2015-01-07 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US9132208B2 (en) | 2008-08-07 | 2015-09-15 | Lifenet Health | Composition for a tissue repair implant and methods of making the same |
US8029575B2 (en) | 2005-10-25 | 2011-10-04 | Globus Medical, Inc. | Porous and nonporous materials for tissue grafting and repair |
US7371260B2 (en) | 2005-10-26 | 2008-05-13 | Biomet Sports Medicine, Inc. | Method and instrumentation for the preparation and transplantation of osteochondral allografts |
US8403985B2 (en) | 2005-11-02 | 2013-03-26 | Zimmer, Inc. | Joint spacer implant |
TWI274591B (en) | 2005-11-07 | 2007-03-01 | Univ Tsinghua | Composite scaffold for remedying articular cartilage tissue and preparation thereof |
EP1951158A4 (en) | 2005-11-21 | 2010-03-31 | Vertegen Inc | Devices and methods for treating facet joints, uncovertebral joints, costovertebral joints and other joints |
EP1973554B1 (en) | 2005-12-07 | 2015-01-14 | Isto Technologies Inc. | Cartilage repair methods |
US20070129630A1 (en) | 2005-12-07 | 2007-06-07 | Shimko Daniel A | Imaging method, device and system |
TWI316860B (en) | 2005-12-29 | 2009-11-11 | Ind Tech Res Inst | Multi-layered matrix, method of tissue repair using the same and multi-layered implant prepared thereof |
US8070810B2 (en) | 2006-01-12 | 2011-12-06 | Histogenics Corporation | Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries |
US7833269B2 (en) | 2006-01-25 | 2010-11-16 | Warsaw Orthopedic, Inc | Osteochondral implant procedure |
US20070179607A1 (en) | 2006-01-31 | 2007-08-02 | Zimmer Technology, Inc. | Cartilage resurfacing implant |
DE102006006904A1 (en) | 2006-02-09 | 2007-08-23 | Universität Rostock | New haemostatic agents and adhesives for medical applications |
US7416889B2 (en) | 2006-04-27 | 2008-08-26 | Rhode Island Hospital | Methods and compositions for repairing cartilage |
US7838022B2 (en) | 2006-05-01 | 2010-11-23 | Warsaw Orthopedic, Inc | Malleable implants containing demineralized bone matrix |
US20070276506A1 (en) | 2006-05-25 | 2007-11-29 | Biomet Manufacturing Corp. | Demineralized osteochondral plug |
US20070299517A1 (en) | 2006-06-21 | 2007-12-27 | Howmedica Osteonics Corp. | Articular cartilage implant |
US7959683B2 (en) | 2006-07-25 | 2011-06-14 | Musculoskeletal Transplant Foundation | Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation |
CN101332314B (en) | 2008-07-22 | 2012-11-14 | 广东冠昊生物科技股份有限公司 | Biotype articular cartilage repair piece |
WO2008021127A2 (en) | 2006-08-08 | 2008-02-21 | Howmedica Osteonics Corp. | Expandable cartilage implant |
US9066994B2 (en) * | 2006-08-31 | 2015-06-30 | Warsaw Orthopedic, Inc. | Demineralized cancellous strip DBM graft |
US8449622B2 (en) | 2006-09-11 | 2013-05-28 | Warsaw Orthopedic, Inc. | Multi-phase osteochondral implantable device |
US8962556B2 (en) | 2006-09-28 | 2015-02-24 | Prochon Biotech Ltd. | FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof |
US20080086142A1 (en) | 2006-10-06 | 2008-04-10 | Kohm Andrew C | Products and Methods for Delivery of Material to Bone and Other Internal Body Parts |
GB0623065D0 (en) | 2006-11-18 | 2006-12-27 | Smith & Nephew | Annular ring |
US20080125863A1 (en) | 2006-11-28 | 2008-05-29 | Mckay William F | Implant designs and methods of improving cartilage repair |
US20080138414A1 (en) | 2006-12-08 | 2008-06-12 | Smith & Nephew, Inc. | Methods of Regenerating Cartilage |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
US20080154372A1 (en) | 2006-12-21 | 2008-06-26 | Peckham Steven M | Osteochondral implant using a growth factor concentration gradient for repair of bone and cartilage tissue |
US8329870B2 (en) | 2007-01-04 | 2012-12-11 | Hepacore Ltd. | Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
US7758643B2 (en) * | 2007-02-26 | 2010-07-20 | Biomet Sports Medicine, Llc | Stable cartilage defect repair plug |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
WO2008128075A1 (en) | 2007-04-12 | 2008-10-23 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
US20080279825A1 (en) | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
US20080294270A1 (en) * | 2007-05-24 | 2008-11-27 | Zimmer Orthobiologics, Inc. | Differentially processed tissue and processing methods thereof |
US8574825B2 (en) | 2007-06-01 | 2013-11-05 | Bacterin International, Inc. | Process for demineralization of bone matrix with preservation of natural growth factors |
US20090024224A1 (en) * | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
US20090081276A1 (en) | 2007-08-13 | 2009-03-26 | Eben Alsberg | Bioresorbable implant composition |
US8685099B2 (en) | 2007-08-14 | 2014-04-01 | Warsaw Orthopedic, Inc. | Multiple component osteoimplant |
US9486317B2 (en) | 2007-08-27 | 2016-11-08 | Arthrex Inc. | Method of arthroscopic osteochondral resurfacing using PRP strengthened with fibrin glue |
US20090069904A1 (en) | 2007-09-12 | 2009-03-12 | Applied Medical Research | Biomaterial including micropores |
US8641774B2 (en) | 2007-09-14 | 2014-02-04 | The Curators Of The University Of Missouri | Synthetic osteochondral composite and method of fabrication thereof |
AU2008311785A1 (en) | 2007-10-19 | 2009-04-23 | Warsaw Orthopedic, Inc. | Demineralized bone matrix compositions and methods |
US8961571B2 (en) | 2007-11-19 | 2015-02-24 | David Lee | Method and apparatus for spinal facet joint fusion using irregularly shaped cortical bone implants |
EP2224884A2 (en) | 2007-12-05 | 2010-09-08 | Musculoskeletal Transplant Foundation | Cancellous bone implant for cartilage repair |
CA2710207C (en) * | 2007-12-21 | 2017-06-06 | Rti Biologics, Inc. | Osteoinductive putties and methods of making and using such putties |
CA2717725A1 (en) * | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
US8043375B2 (en) | 2008-03-06 | 2011-10-25 | MoiRai Orthopaedic, LLC | Cartilage implants |
US20110052533A1 (en) | 2008-03-14 | 2011-03-03 | Regenerative Sciences, Llc | Compositions and Methods for Cartilage Repair |
JP2009291304A (en) | 2008-06-03 | 2009-12-17 | Gc Corp | Bone graft substitute |
US20090312842A1 (en) | 2008-06-16 | 2009-12-17 | Predrag Bursac | Assembled Cartilage Repair Graft |
AU2009268781B2 (en) | 2008-07-06 | 2015-05-07 | The Curators Of The University Of Missouri | Osteochondral implants, arthroplasty methods, devices, and systems |
US20100274362A1 (en) | 2009-01-15 | 2010-10-28 | Avner Yayon | Cartilage particle tissue mixtures optionally combined with a cancellous construct |
US8556972B2 (en) | 2009-04-02 | 2013-10-15 | Sevika Holding AG | Monolithic orthopedic implant with an articular finished surface |
US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
US20120283833A1 (en) | 2009-12-04 | 2012-11-08 | Brannon James K | Articular cartilage treatment method |
US8597317B2 (en) | 2009-12-11 | 2013-12-03 | Taipei Medical University | Method for repair of articular cartilage defect and a device used therein |
US9155607B2 (en) | 2011-11-16 | 2015-10-13 | Purdue Research Foundation | Compositions and methods for repair or regeneration of soft tissue |
US9162011B2 (en) | 2011-12-19 | 2015-10-20 | Allosource | Flowable matrix compositions and methods |
EP3842078A1 (en) | 2011-12-20 | 2021-06-30 | LifeCell Corporation | Sheet tissue products |
WO2013096252A1 (en) | 2011-12-20 | 2013-06-27 | Lifecell Corporation | Flowable tissue products |
US9198758B2 (en) | 2012-01-26 | 2015-12-01 | Warsaw Orthopedic, Inc. | Delivery systems |
US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
US9655994B2 (en) | 2012-07-25 | 2017-05-23 | William F. McKay | Delivery systems |
-
2007
- 2007-01-24 US US11/657,042 patent/US7837740B2/en active Active
-
2008
- 2008-01-23 WO PCT/US2008/051796 patent/WO2008106254A2/en active Application Filing
- 2008-01-23 EP EP08782728A patent/EP2162094A2/en not_active Withdrawn
- 2008-01-23 CA CA2675170A patent/CA2675170C/en not_active Expired - Fee Related
-
2010
- 2010-09-14 US US12/881,988 patent/US8906110B2/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4627853A (en) * | 1985-05-29 | 1986-12-09 | American Hospital Supply Corporation | Method of producing prostheses for replacement of articular cartilage and prostheses so produced |
US6454811B1 (en) * | 1998-10-12 | 2002-09-24 | Massachusetts Institute Of Technology | Composites for tissue regeneration and methods of manufacture thereof |
US6306174B1 (en) * | 1998-12-18 | 2001-10-23 | Benoist Girard Sas | Femoral component |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US20020120274A1 (en) * | 2001-02-26 | 2002-08-29 | Ethicon, Inc. | Tissue scaffold anchor for cartilage repair |
US20040102850A1 (en) * | 2002-11-25 | 2004-05-27 | Shepard Yolanda Denise | Cortical and cancellous allograft spacer |
US20040193268A1 (en) * | 2003-03-31 | 2004-09-30 | Hazebrouck Stephen A. | Intercalary prosthesis, kit and method |
US20040230303A1 (en) * | 2003-05-16 | 2004-11-18 | Gomes Katherine A. | Cartilage allograft plug |
US20050209705A1 (en) * | 2004-03-09 | 2005-09-22 | Niederauer Gabriele G | Implant scaffold combined with autologous or allogenic tissue |
US20060235534A1 (en) * | 2005-04-15 | 2006-10-19 | Gertzman Arthur A | Vertebral disc repair |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE42208E1 (en) | 2003-04-29 | 2011-03-08 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
USRE43258E1 (en) | 2003-04-29 | 2012-03-20 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US8221500B2 (en) | 2003-05-16 | 2012-07-17 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US8652507B2 (en) | 2003-12-11 | 2014-02-18 | Zimmer, Inc. | Juvenile cartilage composition |
US8765165B2 (en) | 2003-12-11 | 2014-07-01 | Zimmer, Inc. | Particulate cartilage system |
US8834914B2 (en) | 2003-12-11 | 2014-09-16 | Zimmer, Inc. | Treatment methods using a particulate cadaveric allogenic juvenile cartilage particles |
US8784863B2 (en) | 2003-12-11 | 2014-07-22 | Zimmer, Inc. | Particulate cadaveric allogenic cartilage system |
US8518433B2 (en) | 2003-12-11 | 2013-08-27 | Zimmer, Inc. | Method of treating an osteochondral defect |
US8524268B2 (en) | 2003-12-11 | 2013-09-03 | Zimmer, Inc. | Cadaveric allogenic human juvenile cartilage implant |
US8292968B2 (en) | 2004-10-12 | 2012-10-23 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
US9701940B2 (en) | 2005-09-19 | 2017-07-11 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US8497121B2 (en) | 2006-12-20 | 2013-07-30 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
US8906110B2 (en) | 2007-01-24 | 2014-12-09 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US9138318B2 (en) | 2007-04-12 | 2015-09-22 | Zimmer, Inc. | Apparatus for forming an implant |
US9364584B2 (en) | 2007-09-14 | 2016-06-14 | Purdue Research Foundation | Demineralized cancellous bone scaffolds |
US8702809B2 (en) | 2007-09-14 | 2014-04-22 | Purdue Research Foundation | Demineralized cancellous bone scaffolds |
WO2009111069A1 (en) * | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
WO2010083051A3 (en) * | 2009-01-15 | 2010-09-23 | ProChon Biotech, Ltd. | Cartilage particle tissue mixtures optionally combined with a cancellous construct |
US10167447B2 (en) | 2012-12-21 | 2019-01-01 | Zimmer, Inc. | Supports and methods for promoting integration of cartilage tissue explants |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
US11555172B2 (en) | 2014-12-02 | 2023-01-17 | Ocugen, Inc. | Cell and tissue culture container |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
US11806443B2 (en) | 2015-08-19 | 2023-11-07 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
US11938245B2 (en) | 2015-08-19 | 2024-03-26 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
Also Published As
Publication number | Publication date |
---|---|
US20110224797A1 (en) | 2011-09-15 |
EP2162094A2 (en) | 2010-03-17 |
US7837740B2 (en) | 2010-11-23 |
CA2675170C (en) | 2014-09-30 |
US8906110B2 (en) | 2014-12-09 |
WO2008106254A3 (en) | 2009-07-30 |
US20080255676A1 (en) | 2008-10-16 |
CA2675170A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7837740B2 (en) | Two piece cancellous construct for cartilage repair | |
US7901457B2 (en) | Cartilage allograft plug | |
US8435551B2 (en) | Cancellous construct with support ring for repair of osteochondral defects | |
US7488348B2 (en) | Cartilage allograft plug | |
US20090149893A1 (en) | Cancellous Bone Implant for Cartilage Repair | |
US7067123B2 (en) | Glue for cartilage repair | |
US20050222687A1 (en) | Cartilage implant assembly and method for implantation | |
US20080274157A1 (en) | Cartilage implant plug with fibrin glue and method for implantation | |
US8795361B2 (en) | Osteochondral plug graft, kit and method | |
US7427293B2 (en) | Osteochondral plug graft, kit and method | |
US20080220044A1 (en) | Cancellous construct with support ring for repair of osteochondral defects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2675170 Country of ref document: CA |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008782728 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08782728 Country of ref document: EP Kind code of ref document: A2 |